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Abstract  
Vitamin E has been the subject of numerous studies over the last nine decades since its 
discovery. Still, the biological activity of vitamin E is not completely understood. Various 
studies suggest that the primary function of vitamin E is a fat-soluble antioxidant preventing lipid 
peroxidation in cellular membranes. The antioxidant efficiency across the vitamin E isomers 
have been shown to be similar in vitro in various organic solvents and aqueous lipid suspensions. 
Despite these results, significantly different biological effects have been observed in biological 
assays supplemented with the various tocols. Furthermore, the differences are more pronounced 
when comparing the biological effects of the α-tocols to non α-tocols. We hypothesized the 
different biological effects observed were correlated to differences in the chemical reactivity of 
the products of tocol oxidation: tocol quinones. Herein, an investigation of the adduct formation 
of tocol quinones with N-acetyl cysteine (NAC) is described.  
The synthesis of the tocopheryl quinones is described via the two-electron oxidation of 
the parent tocols with ceric ammonium nitrate supported on silica. The synthesis of α-tocopherol 
quinone and α-tocotrienol quinone produced the target compounds in 80% yield. The oxidations 
of the other tocol isoforms yielded para-tocol quinones (29-45% yield) and ortho-tocol quinones 
(20-35% yield).  The rate of reaction of the tocopheryl quinones with NAC was monitored by 
following the production of the tocopherol hydroquinone adduct by the increase in absorption at 
308 nm over time in a 67% methanol/ 33% aqueous Tris/HCl buffer. The curves generated were 
fit to a one-phase exponential. The rate of reaction increased as the pH increased for the γ- and δ-
tocopheryl quinone isoforms. There was no reactivity observed between the α-tocopheryl 
quinone isoforms and NAC. There was no significant difference in the reactivity between the 
tocopherol quinones and tocotrienol quinones with the same methylation pattern. At the most 
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physiologically relevant pH in our study (pH = 7.5), the δ-tocopheryl quinones (k ≈ 0.63) reacted 
approximately 8 times faster than the γ-tocopheryl quinones (k ≈ 0.08). The electrochemistry of 
the parent tocols was studied using cyclic voltammetry (CV). The formal redox potential 
increased slightly as the methylation on the chromanol ring decreased while no significant 
differences between the tocopherols and tocotrienols were established. The CV of all tocols 
showed two quasi-reversible one-electron oxidation processes; the first oxidation produced a 
radical cation, which quickly deprotonated to form a tocopheryl radical, which then undergoes a 
second oxidation to the corresponding phenoxonium cation. The redox activity of the tocopheryl 
quinones was also studied using CV. The quinones underwent a quasi-reversible two one-
electron reduction process. The δ-tocopheryl quinones have the lowest formal redox potential 
which slightly increases as methylation increases, while there were no significant differences in 
the electrochemical behavior of the tocopheryl quinones and the tocotrienyl quinones with the 
same methylation. We have presented reaction rate differences in the reactivity of the tocol 
quinones which correlates to the differences in biological activity observed by others with 
respect to the methylation pattern on the chromanol ring, while no differences in the chemical 
reactivity of the tocopherol and tocotrienol quinones was observed. Still, this presents convincing 
evidence that the activity of the tocol quinones should be considered in biological assays. 
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The Synthesis and Reactivity of Vitamin E Quinones 
 
1. INTRODUCTION 
 
1.1 The Vitamin E Family 
 
In 1922 Bishop and Evans studied the effect on rats of a minimalist diet consisting of 
purified protein, fat, carbohydrates, salts, vitamin A, vitamin B, and vitamin C.1  Although 
female rats were able to grow, such animals were sterile. In as early as the second day of 
gestation, blood extravasations in the placentae were observed, increasing in extent until fetal 
resorption occurred. Interestingly, the sterility observed in these rats, as evidenced by fetal 
resorption, was reversed by the implementation of a natural food source such as green lettuce or 
dried alfalfa leaves. Thus, Bishop and Evans concluded that the natural food sources contain a 
dietary factor X, which restores fertility to the sterile rats when supplemented to a minimalist 
diet.1 Shortly after, Barnett Sure identified dietary factor X as vitamin “E”, inspired by the 
nomenclature utilized for the previously discovered vitamins A, B, C, and D.2 This event 
launched an extensive period of studies in the late 1920s which proposed the biochemical 
function of vitamin E as a fat soluble anti-oxidant.3–5 The vitamin was first isolated in 1935 by 
Evans and his research team from wheat germ oil as an oily concentrate. 6 To investigate the 
structure of the vitamin, Evans and his team sought to purify the oily vitamin E concentrate by 
creating a solid derivative. These attempts revealed three crystalline allophanates using cyanic 
acid.6  One of the allophanates was void of biological activity while the other two had biological 
activity similar to that of the vitamin E concentrate. Combustion analysis of the allophanates 
revealed two structurally similar isomers of the vitamin: C29H50O2 and C28H28O2.
6 The C29H50O2 
isomer showed a slight increase in biological activity over the other isomer and was given the 
name: α-tocopherol.6 The other isomer was given the name β-tocopherol.7 The structure of α-
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tocopherol was elucidated in 1938 by Fernholz upon elemental analysis of the thermal 
decomposition and oxidative decomposition of α-tocopherol, which also exposed four members 
of the vitamin E family including: α, β, γ and δ tocopherol.8 A few decades later, four additional 
members of the tocol family were discovered in palm oil: α, β, γ and δ tocotrienol.9 The 
structures of the members of the vitamin E family can be seen in Figure 1.  
The importance of vitamin E was demonstrated early on in several studies using a 
vitamin E deficient diet which resulted in sterility in rats, lymphoblastoma in chicks, and 
muscular dystrophy in guinea pigs and rabbits.1,10–12 The importance of vitamin E is established 
in human patients suffering from ataxia, infertility, and muscle atrophy in a genetic condition 
called ataxia with vitamin E deficiency (AVED).13 Vitamin E deficiency has been shown to be 
the result of a genetic mutation in the gene coding for the plasma transport protein, α-tocopherol 
transfer protein (α-TTP). In a large cohort study of AVED patients, gait impairment was reported 
as the initial onset of symptoms in 93.4 % of subjects.14 Head tremors, cerebellar ataxia, 
blindness, and dysarthria are also reported symptoms of vitamin E deficiency, while some 
patients may be wheel-chair bound by the age of 28.14,15 Consequently, the complications 
observed in vitamin E deficient biological systems solidify its biological significance as an 
essential dietary factor. 
 
 
 
3 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: The structures of the members of the vitamin E family.  
 
Tocols, also known as tocochromanols, are a class of compounds that contain a chroman-
6-ol group with a isoprenoid side chain of sixteen carbon atoms. The degree and position of 
methylation on the chromanol head group is the differentiating factor between α-, β-, γ- and δ-
tocol homologues, α being fully methylated. The three positions of unsaturation on the phytyl 
side chain (3', 7', 11') distinguish the tocotrienols from the fully saturated phytyl side chain of 
tocopherols.9 All tocol homologues have a stereocenter at the 2-position of the chromanol ring in 
the R-configuration, while tocopherols have an additional two stereocenters at the 3' and 7' 
position of the hydrophobic side chain.12 Natural sources of tocopherol exist as the R, R, R-
configuration at the three stereocenters whereas the only stereocenter at the 2-position of the 
tocotrienols is also in the R-configuration and the double bonds are in the E geometry.16 The 
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unsaturation of the phytyl side chain in tocotrienols is responsible for the loss of two additional 
stereocenters present in tocopherol.  
 
1.2 Sources of Vitamin E 
 As mentioned previously, the importance of vitamin E is demonstrated in patients 
suffering from ataxia, infertility, muscle atrophy, and peripheral neuropathy due to vitamin E 
deficiency.14 The lack of the ability of humans to synthesize vitamin E necessitates that it must 
be obtained from dietary sources. The largest sources of vitamin E in the human diet are leafy 
green vegetables, seeds, grains and fruits.17 The different congeners of vitamin E are found in 
various amounts depending on the source, for instance, canola oil is rich in α-, γ, and δ 
tocopherol whereas palm oil is rich in α-tocopherol, α- and γ -tocotrienol.18  
Tocochromanols are synthesized in the chloroplast of plant cells with specific 
stereochemistry.19  Briefly, the synthesis of tocochromanols involves the addition of phytyl 
diphosphate (geranylgeranyl diphosphate for tocotrienols) to homogentisic acid depicted in 
Figure 2.19 This complex goes through an enzymatic-assisted intramolecular cyclization by 
cyclase followed by methylation of the chromanol ring achieved by tocopherol methyl 
transferase enzyme using S-adenosylmethionine.19 Tocopherols occur naturally in the R,R,R-
configuration and naturally occurring tocotrienols have R-configuration stereochemistry at the 2-
position of the chromanol ring.20  
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Figure 2: The biosynthesis of vitamin E. Taken with permission from Yang et al. 19  
 
1.3 Vitamin E Absorption and Transport 
The hydrophobic nature of vitamin E presents a barrier for absorption and transport to 
tissues in the body. Fortunately, evolution has provided the necessary means to overcome this 
barrier using various proteins as seen in Figure 3. After the intake of dietary food, the fats and 
oils, including vitamin E, are solubilized into small micelles by bile acids in the duodenum. 
Initially, it was thought that the uptake of vitamin E by intestinal cells was a process entirely 
mediated by passive diffusion.21 However, one study has demonstrated that the scavenger 
receptor class B type I (SR-BI) is also involved in the uptake of vitamin E by enterocytes.22 Once 
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inside the enterocytes, vitamin E is packed into lipoprotein complexes called chylomicrons and 
re-secreted from the basal side of the intestinal cells into the lymph duct by microsomal 
triglyceride transfer protein (MTP).21,23,24 Once in the bloodstream, the chylomicrons are 
enzymatically hydrolyzed to chylomicron remnants by lipoprotein lipase (LPL). As the 
bloodstream passes through the liver, hepatocytes take up the chylomicron remnants by the 
interaction between the apolipoprotein E segment of the remnant and the LDL receptor-related 
protein (LRP) of the hepatocyte.21 Inside the cytosol of the hepatocytes, α-tocopherol transfer 
protein (α-TTP) is responsible for the retention of tocols. In vitro and in vivo studies have 
demonstrated that this protein binds with high selectivity to R,R,R-α-tocopherol compared to 
other isoforms of vitamin E as depicted in Table 1.13,21,25,26   The dissociation constant, Kd, was 
significantly lower and the relative affinity was significantly greater for α-tocopherol with α-TTP 
compared to the other ligands tested in vitro using tritium labelled α-tocopherol competition 
assays indicating a greater selectivity towards α -tocopherol.27 The high selectivity for α-
tocopherol by α-TTP is demonstrated in humans by significantly higher levels of plasma α-
tocopherol (~32 µM) compared to the other tocols which are present in concentrations lower than 
2 µM.28 The evolutionary advantage regarding the high selectivity towards α-tocopherol is 
unknown and of particular interest. Nonetheless, the tocols retained by the α-TTP in the 
hepatocytes are packed into very-low density lipoproteins (VLDL) and exported throughout the 
bloodstream. The phospholipid transfer protein (PLTP) has been shown to be associated with α-
tocopherol transfer between VLDLs and other circulating lipoproteins such as high density 
lipoproteins (HDLs) and low density lipoproteins (LDLs).29 The tissues absorb the vitamin E 
containing lipoproteins by various receptors such as low-density lipoprotein receptors (LDLR) 
and SR-BI or by the PLTP ligand exchange pathway.21  
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Table 1: Comparison of ligand specificity of α-TTP for various tocopherol derivatives and the 
biological activity. Table taken with permission from Panagabko et al. 27  
 
As seen in Figure 3 vitamin E can also undergo an alternative absorption pathway in the 
absence of an exogenous lipid supply. It can be packed into high density lipoprotein (HDL) 
inside enterocytes and secreted into the lymph duct by the trans-membrane transporter ATP-
Binding Cassette A-1 (ABCA1) protein.21,23 The HDL containing vitamin E can be directly 
absorbed by peripheral tissues with the use of ABCA1 and plasma phospholipid transfer protein 
(PLTP).21,23 Tocols reside in the phospholipid bilayers of the cell with the phenolic group 
directed towards the polar phosphate head groups of the membrane phospholipids.30  
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Figure 3: A schematic of the absorption and transport of vitamin E in humans.21 See main text 
for details. α-TTP- α-tocopherol transfer protein, ABCA1- ATP-Binding Cassette A-1, HDL- 
high density lipoprotein, LDL- low-density lipoprotein, LDLR- low-density lipoprotein 
receptors, LPL- lipoprotein lipase, LRP- LDL receptor-related protein, MTP- microsomal 
triglyceride transfer protein, PLTP- plasma phospholipid transfer protein, SR-BI- scavenger 
receptor class B type I, TAPs VLDL- very-low density lipoprotein. Figure taken with permission 
from Lemaire-Ewing et al.21 
 
Tocols that are not retained are either excreted into the bile or feces, or degraded and 
excreted in the urine.21 The major tocol degradation products found in the urine are carboxyethyl 
hydroxychromans (CEHCs). These products are derived from enzymatic degradation in the liver 
achieved mainly by cytochrome P450 4F2 (CYP4F2) via a ω-hydroxylation pathway starting at 
one of the terminal methyl groups of the phytyl side chain.31 The hydroxylation product is further 
oxidized to the corresponding carboxylic acid followed by a series of β-oxidations to yield the 
corresponding CEHC as seen in Figure 4.31,32 In addition to the preferential retention of α-
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tocopherol by α-TTP, it has been shown that the activity of the CYP4F2 enzyme is several fold 
greater towards non α-tocopherol isoforms of vitamin E.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: The pathway of hepatic metabolism of γ-tocopherol to its corresponding CEHC 
metabolite.31 
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1.4 Vitamin E as an Antioxidant 
 
The aerobic nature of mammalian metabolism presents the cell with a potential for 
oxidative stress induced by a variety of free radicals derived from oxygen, also known as 
reactive oxygen species (ROS).33 It is well known that the biological significance of vitamin E is 
to protect the cell from such oxidative stress.34 Due to the location of vitamin E inside the cell 
(i.e. the phospholipid bilayer) vitamin E is exposed to a limited variety of ROS.35 There are few 
reactive oxygen species that are capable of entering the lipid bilayer; the hydroxyl radical (•OH), 
protonated superoxide radical (HOO•), and peroxynitrites (ONOO•) being the most biologically 
significant ROS in the bilayer.34,36 The hydroxyl radical can be generated by the reductive 
cleavage of hydrogen peroxide by iron(II). This is known as the Fenton reaction which is 
illustrated in Figure 5.35 Inside the bilayer, ROS are capable of initiating lipid peroxidation 
which disrupts the integrity of the cellular membrane.  
 
 
Figure 5: Hydroxyl radicals generated by the Fenton reaction. 35 
 
Lipid peroxidation is initiated when a free radical abstracts a hydrogen atom from a 
carbon center of a lipid.33,35 The lipids most inclined to hydrogen abstraction are polyunsaturated 
fatty acids (PUFAs), particularly PUFAs with a 1,4-pentadiene group. These PUFAs contain two 
bis-allylic hydrogen atoms that are susceptible to hydrogen abstraction because the carbon-
centered radical generated is resonance stabilized as seen in Figure 6. The carbon-centered free 
radical quickly reacts with molecular oxygen which produces a lipid peroxyl radical.33,35Lipid 
peroxyl radicals are capable of abstracting hydrogen atoms from other PUFAs in the bilayer, a 
process known as chain-reaction lipid peroxidation.35 The progression of this process is 
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devastating as the integrity of cellular membranes would be compromised.35 Fortunately, various 
in vivo and in vitro studies demonstrate the capacity of tocols to prevent lipid peroxidation by 
scavenging lipid peroxyl radicals.34  
 
 
 
 
 
 
 
 
 
 
 
Figure 6: The inhibition of lipid peroxidation by tocopherol in lipid membranes. 
 
The chemical properties and location in membranes of tocols make them ideal for 
preventing lipid peroxidation.35 Carbon-6 on the chromanol ring of tocols contains a phenolic 
hydrogen which is prone to hydrogen atom abstraction by lipid peroxyl radicals. This terminates 
the lipid peroxidation chain reaction and the tocopheroxyl generated is resonance stabilized.35 
The lipid hydroperoxide generated can be reduced to an alcohol by enzymes such as 
glutathione:hydrogen-peroxide oxidoreductase (GPx-1) which uses glutathione as a reducing 
agent.37  
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The location of the tocols in the membrane is also important for this antioxidant 
mechanism. The chromanol headgroup of the tocopherols reside near the glycerol backbone of 
the phospholipid bilayer whereas the tail is buried into the hydrophobic core of the bilayer. The 
location of the chromanol headgroup near the lipid/aqueous interface enables it to intercept free-
radicals found in the aqueous environment from reaching the unsaturated bonds of the 
hydrocarbon chains.38 In addition, in the case where a lipid peroxide is generated, the acyl chain 
may diffuse towards the membrane surface owing to its increased hydrophilicity.38 The height of 
α-tocopherol in the bilayer, measured by the distance from the center of the bilayer, can vary 
slightly depending on the lipid composition of the local environment.38 The proximity of the 
tocopheroxyl radical to the aqueous membrane surface allows tocols to be recycled by water 
soluble reducing agents such as ascorbate.35 Consequently, the ROS radicals are removed from 
the lipid membrane and lipid peroxidation is terminated.  
 Over the past few decades, the literature has been focused on the tocopherols capacity to 
be a lipid peroxidation chain-breaking antioxidant. This is achieved by generating the resonance 
stabilized tocopheroxyl radical which can be recycled by water-soluble reducing agents such as 
ascorbate.35,39 The rate of reduction of the tocopheroxyl radical to the tocopherol is of course 
highly dependant on the concentration of the reducing agent. If the concentration of the reducing 
agents are low enough, the radical may undergo several competing reactions such as 
dimerization, addition reactions with other lipid peroxyl radicals or even a second-electron 
oxidation leading to the formation of a quinone.39 
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Some studies suggest that differences observed in vivo might be associated with 
properties not related to the antioxidant function of vitamin E.40 It has been suggested that α-
tocopherol might be involved in the inhibition of protein kinase c (PKC) by activation of protein 
phosphatase 2A, modulate the activity of cytosolic phospholipase A2 (cPLA2), stimulating the 
release of cytokines, and anti-inflammatory responses.40 Such effects were not observed with a 
diet supplemented with β-tocopherol.40 On the other hand, some researchers argue that the 
difference in biological effects are still related to the antioxidant function of α-tocopherol.34 
When bovine pulmonary artery endothelial cells were stimulated with peroxynitrite, an oxidative 
stress inducer, the activity of PKC and cPLA2 also increased.
41 Therefore, if oxidative stress 
increases the activity of these enzymes, then it would be reasonable that an antioxidant such as α-
tocopherol decreases their activity by reducing oxidative stress.34 It is hypothesized that the 
biological effects observed are due to changes in oxidative stress or membrane properties 
(fluidity and packing errors).34,42 The differences in biological activities between the vitamers 
may be explained by three reasons: the chromanol head of α-tocopherol sits higher in the 
membrane than the other vitamers, because the concentration of α-tocopherol is much higher 
than other tocols in vivo, or because the tocopherols may exhibit different antioxidant 
efficiencies in membranes.34,42,43  
 
       1.5 Biological differences among tocol isoforms 
 
The antioxidant capabilities across the tocol family is well described in vitro in various 
solvents and lipid suspensions.34,44–47 In one study, the antioxidant activity of the tocols were 
tested in a competition reaction against pyrogallolsulfonphthalein (PG) using 2,2'-azobis(2,4-
dimethylvaleronitrile) (AMVN) as a radical initiator. The antioxidant activity of the tocols 
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decreased in the order of α- > γ- ≈ β- > δ-tocopherol, while no significant difference was 
observed between the tocopherols and tocotrienols within the respective chromanol substitution 
patterns.47 Traber and Atkinson have reviewed the literature that described a similar rank order 
across the tocol family with respect to the hydrogen atom abstraction rate constants in various 
solvents as seen in Table 2.34 Although these studies demonstrate the possibility to rank the 
antioxidant ability across the tocol family, the differences are minimal compared to the much 
more significant biological differences seen in the fetal resorption assay seen in Table 2.34 The 
differences in the fetal resorption assay can be attributed to the preferential retention and 
distribution of α-tocopherol by the hepatic α-tocopherol transfer protein and higher metabolism 
of the other isomers by Cyp 4F2.13,17,34 Nonetheless, the reason for preferential retention of α-
tocopherol in animals over the other isoforms remains unknown. 
 
Table 2: The antioxidant capabilities of the tocopherols in various media. Table taken with 
permission from Traber & Atkinson. 34  
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It would be attractive to answer this question by observing various effects in vivo in 
animal trials supplemented with different isoforms of vitamin E. However, the preferential 
absorption and distribution of α-tocopherol over the other isoforms presents a significant barrier. 
To overcome this issue, some studies sought to evaluate the difference in cell culture assays, 
some of which are discussed here.44 Up to the 1990s, much of the research on vitamin E was 
dedicated to α-tocopherol because it is the most biologically active isoform of the vitamin.44 In 
1997, Christen et al. were curious as to why the supplementation of α-tocopherol failed to 
produce any protective effects on coronary heart disease in a large cohort of post-menopausal 
women,48 or reduce the risk of lung cancer in a randomized, double-blind placebo controlled 
prevention trial in male smokers.49,50 Their hypothesis was that supplementation of α-tocopherol 
lowers the concentrations of γ-tocopherol in plasma and other tissues. As such, the difference in 
the ability to inhibit peroxynitrite induced lipid peroxidation between α and γ-tocopherol in 
phosphatidylcholine (PC) liposomes from soybeans as well as in human LDL was examined. It 
was found that γ-tocopherol was significantly more efficient at preventing PC hydroperoxide 
(PC-OOH) formation compared to α-tocopherol as seen in Figure 7A. Furthermore, the rate and 
amount of of PC-OOH formation in PC liposomes treated with 1 mM 3-morpholinosydnonimine 
(SIN-1), a nitric oxide generator, was significantly reduced when comparing γ-tocopherol to α-
tocopherol as seen in Figure 7B.49  In contrast, it was found that α-tocopherol was slightly more 
efficient at inhibiting the formation of cholesteryl ester hydroperoxides (CE-OOH) in human 
LDL treated with 0.2 mM SIN-1. To rationalize these results, the mechanism of inhibition of 
peroxynitrite induced lipid peroxidation by the tocopherols was accomplished by characterizing 
the products of reaction with nitrous acid (HNO2). Indeed, fundamentally different reactivities 
between α and γ-tocopherol were reported as seen in Figure 8: α-tocopherol underwent a two 
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electron oxidation to form α-tocopherol quinone whereas γ-tocopherol formed a 5-nitro-γ-
tocopherol derivative in greater than 90% yield.49 In the liposome experiments, α-tocopherol was 
oxidized almost quantitatively to α-tocopherol quinone (90%) and γ-tocopherol formed an ortho-
γ-tocopherol quinone product called tocored (~25%), 5-nitro-γ-tocopherol derivative (50%) and 
25% remained unreacted.49 This study demonstrates the difference in electrophilic nature of the 
5-position of γ-tocopherol compared to α-tocopherol. It is suggested that the supplementation 
with only α-tocopherol should be reconsidered because it suppresses the levels of γ-tocopherol in 
vivo.49  
 
 
Figure 7: A) The inhibition of PC-OOH formation in PC liposomes by 0.1mM α-tocopherol 
(open circles) and γ-tocopherol (closed circles) using various concentrations of peroxynitrite. B) 
The effect of 20 µM α-tocopherol (open circles), γ-tocopherol (closed circles) and without 
tocopherols (open triangles) on the rate of PC-OOH formation in PC liposomes treated with 
1mM 3-morpholinosyndonimine (SIN-1) to induce PC-OOH formation. Figure taken with 
permission from Christen et al. 49  
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Figure 8: The reaction products of α and γ-tocopherol in the presence of peroxynitrite. The 
major product of α-tocopherol is highlighted in red and the major products of γ-tocopherol are 
highlighted in blue. Figure taken with permission from Christen et al.49  
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 A few years later, McCormick and Parker were interested in the effects of 
supplementation of the different tocopherols (α, γ and δ) on the cell viability of a mouse 
macrophage tumour cell line, RAW 264.7.51 Interestingly, drastic differences in cytotoxicity 
were observed between the tocopherol vitamers: δ-tocopherol being more cytotoxic than γ-
tocopherol, whereas no cytotoxicity was observed with α-tocopherol as seen in Figure 9. The 
doses are within the physiological range of 30-60 µM for the concentration of α-tocopherol in 
human plasma.51 Next, the effect of the different isoforms on cell viability in various cell lines 
was of interest. Of all the cell lines tested: primary mouse macrophages, human breast cancer 
cell line (MCF-7), mouse fibroblasts (NIH 3T3), human hepatocytes (HepG2) and bovine 
endothelial cell (endo), the HepG2 and the endo cells appeared resistant to the cytotoxic effects 
of γ and δ-tocopherol. The other cell lines followed the same rank order of cytotoxicity (i.e. δ > γ 
>> α) as the RAW 264.7 cell line. Interestingly, the HepG2 showed only a ~20% accumulation 
of tocopherols compared to the macrophage cell line owing to hepatic metabolism which may 
explain its resistance to cytotoxicity. Moreover, no significant difference in accumulation 
between the different tocopherols was observed in all cell lines, indicating that the cytotoxic 
properties of γ and δ-tocopherol are not a result of differences in cellular accumulation of the 
vitamers. By analysis of caspase-3 activity and DNA fragmentation in the RAW 264.7 cells 
incubated with various concentrations of δ-tocopherol, it was concluded that δ-tocopherol is 
associated with apoptosis, though the mechanism is not clear.51 These results suggest that the 
degree of methylation on the chromanol ring may correlate to the cytotoxicity observed. 
Furthermore, it may explain the preferential retention of the less toxic α-tocopherol over the 
other isoforms of vitamin E.51 
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Figure 9: The cell viability of a mouse macrophage cell line RAW 264.7 after incubation with 
different tocopherols for 24 hours (n=4). Figure taken with permission from McCormick & 
Parker.51   
 
More recently, Elisia and Kitts investigated the effect of α-,γ- and δ-tocopherol on 
interferon gamma/phorbol myristate acetate (IFNγ/PMA) induced pro-inflammatory oxidative 
conditions of Caco-2 cells.52 More specifically, the study aimed to explore the effect of the 
different tocopherol isoforms on the inflammatory response and the oxidative stress-activated 
cell signaling pathways that involve the transcription factor complexes Nf-κB and Nrf-2. The 
inflammatory response was measured by levels of interleukin-8 (IL-8), a peptide secreted by 
macrophages during inflammatory responses. In theory, the higher the levels of IL-8, the less 
effective the tocopherol is at inhibiting the inflammatory response. As mentioned previously, Nf-
κB is an oxidative stress-activated transcription factor responsible for the expression of 
cytokines, whereas Nrf- 2 is a transcription factor, activated under oxidative stress, that is 
responsible for the expression of various antioxidant enzymes. The experiments performed by 
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Elisia and Kitts used three concentrations of tocopherols: 1, 10 and 100 µM. No significant 
effects were observed at 1 and 10 µM in most of the experiments. Thus, most of the conclusions 
obtained from these experiments were extracted from the results at 100 µM. It was observed that 
IL-8 secretion was inhibited in decreasing order of γ>α>δ when cells were incubated with 100 
µM tocopherols as seen in Figure 10A. However, at 10 µM, α-tocopherol showed no effect on 
IL-8 secretion whereas a ~40 % reduction in IL-8 secretion was observed in γ and δ-tocopherol. 
It would be interesting to measure the effect of tocopherol isoforms on IL-8 secretion at more 
physiologically relevant concentrations. The attenuation of the Nf-κB pathway was most 
prominent in α-tocopherol while no clear concentration dependant relationship was established 
with γ and δ-tocopherol (Figure 10C). In contrast, a significant difference in the activation of the 
Nrf-2 pathway was observed between the tocopherol isoforms as seen in Figure 10B. δ-
Tocopherol had the greatest effect on the activation of the Nrf-2 pathway and showed significant 
activation even at 10 µM. γ-Tocopherol showed a significant effect on the activation of Nrf-2 at 
100 µM, however no significant effect was observed with α-tocopherol at any concentration. 
These experiments suggest that tocopherol isoforms have distinct capabilities in modulating cell 
signaling pathways related to the oxidative status of the cell.52 The authors proposed that the 
oxidation of tocopherols results in the formation of water soluble tocopherol derived radicals 
which may impart pro-oxidant activity in the cytosol. They suggested that the differences may be 
attributed to the polarity of the isoforms; δ-tocopherol is the most polar isoform, therefore, the 
pro-oxidant δ-tocopherol derived radicals would be more partitioned in the cytoplasm.52 More 
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insight into the distinct mechanisms of Nf-κB and Nrf-2 activation by tocopherol isoforms is 
warranted. 
Figure 10: A) The effect of tocopherol isoforms on the levels of IL-8 in a IFNγ/PMA induced 
inflammatory and oxidative response conditions of a Caco-2 cell line compared to a control. B) 
The effect of tocopherol isoforms on the Nrf-2 activation in a IFNγ/PMA induced inflammatory 
and oxidative response conditions of a Caco-2 cell line compared to a control C) The effect of 
tocopherol isoforms on the Nf-κB activation in a IFNγ/PMA induced inflammatory and oxidative 
response conditions of a Caco-2 cell line compared to a control. In all cases, the values refer to 
the percentage of differences between a negative and positive control: the negative control being 
Caco-2 cells without IFNγ/PMA and tocopherols, the positive control being Caco-2 cells 
incubated with IFNγ/PMA but without tocopherols. Figure adapted from Elisia & Kitts.52  
 
The previously mentioned studies demonstrate the differences between the tocopherol 
isoforms, however, the effects of the tocotrienols were neglected. Unfortunately, most of the 
literature on vitamin E is performed with α-tocopherol. Equally concerning is that, the majority 
22 
 
of the research on tocotrienols is performed using a tocotrienol rich fraction (TRF) derived from 
palm oil which contains a mixture of tocopherols and tocotrienols.44 Thus, the effects observed 
can not be attributed to a specific tocol isoform in these studies using unpurified TRF. 
Nonetheless, some studies have suggested that tocotrienols may exhibit increased anti-cancer, 
anticholesterolemic, anti-inflammatory, cardioprotective and neuroprotective properties 
compared to tocopherols.44 To focus in on the difference between tocotrienols and tocopherols, it 
would be wise to compare the tocopherol and tocotrienols having the same methylation pattern, 
given the different effects observed between the tocopherol isoforms. That is, α-tocopherol 
should be compared to α-tocotrienol, γ-tocopherol compared to γ-tocotrienol, and so on.   
There are few reports in the literature examining different biological effects between α-
tocopherol and α-tocotrienol. As mentioned previously, it is difficult to study the effects in vivo 
due to the preferential retention of α-tocopherol by α-TTP. Nonetheless, in the 1980s, Qureshi et 
al. noticed that populations that consumed diets rich in cereal grains had a lower incidence of 
cardiovascular disease owing to lower levels of cholesterol.53 They demonstrated that barley was 
the most effective cereal grain in lowering blood cholesterol levels in animal trials out of the 
cereal grains tested.53 Furthermore, they had demonstrated that the lower levels of cholesterol 
was the result of a suppressive action on the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-
CoA) reductase enzyme.53 HMG-CoA reductase is the rate-limiting enzyme in the mevalonate 
pathway of the biosynthesis of isoprenoids including cholesterol.53 The sequential extraction of 
barley flour using petroleum ether yielded a fraction with HMG-CoA reductase inhibitory 
properties. The isolation of the components of the petroleum ether soluble fraction yielded 10 
compounds, two of which (compounds I and II) demonstrated HMG-CoA reductase inhibitory 
properties. Compound I was characterized as α-tocotrienol by mass spectrometry and no 
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comment on the identify of compound II was offered. The dietary administration of α-tocotrienol 
to broiler cockerels for 21 days showed a concentration dependant inhibition on the activity of 
HMG-CoA reductase in the hepatocytes as seen in Table 3.53  This study may demonstrate 
potential benefits of tocotrienols over tocopherols because the rank of grains in the order of their 
increasing effect on the suppression of cholesterol biosynthesis as measured by the cholesterol 
concentrations in chicks was: corn (100% or 139 ± 7 mg/100 mL in plasma, 100% or 318 ± 17 
mg/100 g in liver), wheat (76%, 80%), rye (75%, 79%), oats (68%, 75%), and barley (55%, 
65%).  The tocol concentrations in these cereal grains (mg/kg) are: corn (23.6), wheat (35.0), rye 
(44.6), oats (17.8), and barley (30.5); it would be expected that the rank order for cholesterol 
inhibition correlates to the total tocol concentration. However, it is interesting because an 
increase in tocol contents do not correlate with the observed suppression of cholesterol 
concentrations. On the other hand, the tocotrienols as per cent of tocols are: corn (15%), wheat 
(61%), rye (62%), oats (71%) and barley (81%).53,54 This measure (tocotrienols as percent of 
total tocols) reflects more closely the cholesterol-suppressive pattern of these grains than does 
the measure of the quantity of tocols. The inhibitory mechanism of α-tocotrienol on HMG-CoA 
reductase may be similar to that of squalene or ubiquinone-9 which all share an isoprenoid chain 
but no specific mechanism of inhibition was offered.53 The authors suggested that the inhibition 
of the mevalonate pathway from one of the multiple end products (squalene, vitamin K, 
cholesterol, etc.) will decrease not only its own production, but also that of the products of the 
other branches. Therefore, it is plausible that the isoprenoid chain of the tocotrienol mimics the 
isoprenoids of the mevalonate pathway and inhibits their production through an end product 
inhibition.53  
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Table 3: Concentration-dependent effects of dietary d-α-tocotrienol on cholesterol metabolism 
in broiler cockerels. Feeding period, 21 days, fast 2, refed 3; n = 9. Table taken with permission 
from Qureshi et al.53 
 
 
 A few years later, Pearce et al. set out to extend the original findings of Qureshi et al. by 
examining the effects of synthetic α-tocotrienol on a cholesterol biosynthesis assay in primary rat 
hepatocytes.55 In their investigations, the synthetic d,l- α-tocotrienol was substantially less active 
(17% inhibition of cholesterol biosynthesis at 210 µg/mL) in primary rat hepatocytes compared 
to tocotrienol fraction isolated from barley flour (31% at 138 µg/mL) even while factoring in the 
racemic mixture of the synthetic α-tocotrienol.55 Around the same time, the researchers received 
a tocotrienol rich fraction (TRF) from palm oil. The TRF was subjected to flash chromatography 
and HPLC which identified the following components: d-α-tocopherol (26%), d-α-tocotrienol 
(18%), d-γ-tocotrienol (27%), and d-δ-tocotrienol (7%). The isolated tocols were assayed in vitro 
in human hepatoma HepG2 cells as seen in Table 4.55 The cholesterol synthesis assay was 
measured by the amount of 14C-acetate incorporated into cholesterol after incubation. As seen in 
Table 4, only 3 ± 1 % inhibition of cholesterol synthesis was observed in cells incubated with γ-
tocopherol. Remarkably, the natural d-tocotrienols demonstrated at least a 32 ± 4 % inhibition as 
seen with α-tocotrienol. The effects are even more pronounced with d-γ-tocotrienol and d-δ-
tocotrienol which showed 78 ± 3 % and 77 ± 4 % inhibition respectively. The little activity 
observed with γ-tocopherol highlighted the importance of the unsaturated phytyl chain of 
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tocotrienols in the inhibition of cholesterol synthesis. The inhibition of cholesterol synthesis by 
tocotrienols can be attributed to a reduction in the activity of HMG-CoA reductase as seen in 
Table 4.55 The authors speculated that the mechanism of inhibition appears to involve the down-
regulation of HMG-CoA reductase and not direct inhibition because the addition of γ-tocotrienol 
to an isolated microsomal HMG-CoA reductase fraction from HepG2 cells did not influence its 
activity.55 Furthermore, the tocotrienols were shown to inhibit the incorporation of 14C labeled 
acetate but not mevalonate into sterol which suggests a suppressive action on the HMG-CoA 
reductase enzyme.55 The mechanism of inhibition was further investigated by Parker et al. of the 
same group a year later.56 Using immunoblot protein quantification and mRNA quantification by 
slot-blot hybridization, the researchers determined that the mechanism of inhibition by 
tocotrienols involves a post-transcriptional process controlling the rate of degradation of the 
HMG-CoA reductase enzyme.56 The mechanism of action for controlling the rate of degradation 
remains unclear.  
Table 4: The effect of various tocols on the inhibition of cholesterol synthesis and HMGR 
activity in human HepG2 cells. Table taken with permission from Pearce et al.55  
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Inspired by previous reports which suggested promising anti-tumour activity exhibited by 
tocotrienols, Fu et al. sought to overcome the limited bioavailability barrier by using a novel 
drug transport system.57 The authors recognized the need for iron in tumor cell growth, which is 
carried to cells by the transferrin protein. They demonstrated that an intravenous injection of a 
lipid vesicle containing a tocotrienol rich fraction (TRF) linked to a transferrin protein could be 
efficiently delivered and exhibit anti-tumor activity in mice. The shortcoming of these studies 
was that the TRF contains a mixture of tocopherols and tocotrienols so the extent of activity from 
each vitamer could not be examined.  Recently, the same group aimed to investigate the effect of 
the individual tocols loaded in a transferrin linked lipid vesicles delivery system on two cancer 
cell lines: B16-F10 murine melanoma and A431human epidermoid carcinoma. As seen in Table 
5, α-tocopherol and α-tocotrienol loaded transferrin vesicles exhibited the slightly greater effects 
on cell viability in the B16-F10 cell line expressed by the lowest IC50 values. The IC50 is the 
concentration required to inhibit the growth of the cell population by 50%.  It is interesting that 
the α-tocotrienol loaded transferrin vesicle exhibited a significantly greater effect on A431 cell 
viability compared to the other isoforms. Because the α-tocotrienol loaded delivery system 
exhibited the greatest anti-cancer cell growth activity in both cell lines tested, the researchers 
determined the α-tocotrienol loaded delivery system in vivo in female immuno-deficient BALB/c 
mice implanted with A431 or B16-F10-luc-G5 cancer cells in exponential growth. The effects of 
the other tocol loaded vesicles were not assayed in vivo. As seen in Figure 11, significant tumour 
growth attenuation was achieved in both cancer types using the α-tocotrienol loaded delivery 
system compared to the controls.58 The authors provide no insight into the mechanism of 
increased anti-cancer properties of α-tocotrienol which warrants future investigation.58 In another 
study, α-tocotrienol was shown to exhibit inhibitory effects on human Tenon fibroblasts, a cell 
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responsible for scarring following eye surgery,  at concentrations of 50 µM by as much as 40%, 
whereas no inhibitory effects were observed with α-tocopherol in concentrations as high as 100 
µM.59   
Table 5: The efficacy of tocol isoforms on cancer cell viability. The control vesicles consist of 
tocol containing lipid vesicles not linked to transferrin. Table taken with permission from Karim 
et al.58 
 
 
Figure 11: Tumor growth studies in a mouse A431 model (A) and a mouse B16-F10 model (B) 
after intravenous administration of transferrin-bearing vesicles entrapping α-tocotrienol, α-T3 
(10 μg/injection) (green). Controls: lipid vesicles entrapping α-T3 (orange), free α-T3 solution 
(red), untreated tumors (black). Figure taken with permission from Karim et al.58 
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In 2000, Yu et al. investigated the apoptosis-inducing properties of tocols in estrogen-
responsive MCF7 and estrogen-nonresponsive MDA-MB-435 human breast cancer cell lines.60 
After 3 days of incubation with the tocols, the cells were stained with 4,6-diamidino-2-
phenylindole (DAPI) which selectively stains A-T rich regions of DNA to allow visualization of 
the chromatin structure by fluorescence microscopy. Cells with clearly condensed chromatin or 
exhibiting nuclei fragmentation were scored as apoptotic. The number of apoptotic versus non-
apoptotic cells were counted to report an EC50 value, the concentration (in μg/ml) of the 
compound needed to induce apoptotic morphology in 50% of the cells.60 As seen in Table 6, 
only the δ-tocopherol isoform showed any apoptotic properties  amongst the tocopherol family. 
In contrast, the tocotrienols were significantly more effective at inducing apoptotic properties in 
the MCF7 cell line in the decreasing order: δ-tocotrienol > α-tocotrienol ≈ γ-tocotrienol > δ-
tocopherol.  In the MDA-MB-435 cell line, the same rank order is achieved except α-tocotrienol 
is less effective, and comparable to the properties of δ-tocopherol. Interestingly, the α-tocopherol 
succinate derivative demonstrated significant pro-apoptotic properties with an EC50 of 7 ± 1.0 
µg/mL, whereas no significant apoptotic stimulation was observed with α-tocopherol or its 
acetate derivative. The cellular and molecular events responsible for the apoptotic properties 
observed by the tocols were not established in this study, however the authors postulate various 
reasons related to increased expression of different proteins involved in apoptosis.60 
Unfortunately, the molecular mechanism of increased expression of these proteins by tocols is 
not known.60,61  
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Table 6: Comparison of apoptotic properties of various tocols in two human breast cancer cell 
lines. Table taken with permission from from Yu et al.60 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In another study, researchers observed the cytotoxicity of different isoprenoids on a 
culture of murine B16 (F10) melanoma cells.62 The cells were incubated for 24 hours prior to the 
introduction of the various tocols. They reported the cytotoxicity as an IC50 value: the 
concentration needed to inhibit the growth of the culture by 50%. α-Tocotrienol had a much 
higher IC50 value (110 μmol/L) than γ- tocotrienol (20 μmol/L) and δ-tocotrienol (10 μmol/L) as 
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seen in Figure 12.62 Importantly, no cytotoxicity was observed with cells incubated with α-
tocopherol.  
Figure 12: The viability of melanoma B16 cells 48 hours after the incubation with various 
tocols. Figure taken with permission from He et al.62 
 
In summary, the antioxidant activities across the isoforms of the vitamin E family are 
very similar. However, drastic differences have been observed in measures of biological activity 
using cell culture assays. McCormick and Parker show that in a RAW 264.7 macrophage cell 
line, δ-tocopherol exhibited greater cytotoxicity than γ-tocopherol whereas α-tocopherol was not 
cytotoxic.51 Elisia and Kitts have demonstrated that α-tocopherol may be involved in the 
mitigation of Nf-κB pathway in a Caco-2 cell line whereas γ and δ-tocopherol showed little 
effect. Furthermore, they demonstrated that δ-tocopherol had much greater effect on the 
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activation of the Nrf-2 cell signaling pathway compared to γ-tocopherol, while α-tocopherol 
showed no significant activity on this pathway.52 In addition, various studies described above 
have shown biological properties unique to the tocotrienols. It would seem unreasonable to 
appoint such drastic biological differences to rather minor differences in antioxidant activity. The 
in vivo preference for α-tocopherol may then rest on the potential cytotoxic activity of the other 
tocols. That being said, low concentrations of the other tocols may be required to maintain a 
certain balance of cell signalling within the cell. Cornwell et al. have demonstrated the potential 
for biological differences arising from the formation of tocopherol derived oxidative products: 
vitamin E quinones. 63–65 The formation of quinones in vivo is the result of a one electron 
oxidation of the parent tocols to produce the radical cation, the subsequent loss of a proton and 
then a second electron oxidation produces the phenoxonium cation that reacts with water and 
thus the formation of the quinone in a mechanism like the one seen earlier in Figure 8.  
 
1.4 Tocol Quinones 
 
The difference in biological effects observed between the tocopherols may in fact be 
imparted by distinct biochemical properties between the tocol derived quinones.63–65 The non α-
tocols are oxidized to electrophilic arylating quinones which can form adducts with free thiol 
groups of proteins by a Michael addition mechanism. In contrast, the fully substituted chromanol 
ring of α-tocol quinone is not susceptible to Michael addition.63–65 Indeed, Cornwell’s group has 
reported the synthesis of glutathione adducts with γ and δ-tocopherol quinone, but not with α-
tocopherol quinone.63,66 Furthermore, they suggested that δ-tocopherol quinone should be more 
reactive towards nucleophiles than γ-tocopherol quinone because the lack of an electron donating 
methyl group makes it more electrophilic. This may be responsible for the differences observed 
between γ- and δ-tocopherol in cell culture assays where they can be oxidized to the 
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corresponding quinones, and the rate of reactivity with cellular thiol nucleophiles may correlate 
to the cytotoxicity observed.  However, there is no chemical evidence to prove such rates of 
reactivity, thus it would be interesting to investigate this matter. Nonetheless, further evidence 
for the difference between arylating tocols and non-arylating tocols was revealed when smooth 
muscle cells and human acute lymphoblastic leukemia cells were treated with α-tocopherol 
quinone and γ-tocopherol quinone. Almost no effect was observed in both cell cultures treated 
with α-tocopherol quinone.66 Contrarily, cytotoxicity was prominent in both cell cultures treated 
with γ -tocopherol quinone.66 The mechanism for non α-tocol quinone arylation is illustrated in 
Scheme 1. Arylating tocol quinones are suggested to be involved in a variety of cell signalling 
pathways through protein arylation at reactive cysteine residues.63–66 We suggest that the 
difference in biological activity observed between the tocols reflects the rate of reactivity of the 
tocol quinones with thiols.  
 
Scheme 1: The protein arylation mechanism of non α-tocol quinones 
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1.5 Reactive Thiols in Cells 
 
 It has been argued that the origin of the eukaryotic cell is marked by the acquisition of the 
mitochondrion through the endocytosis of bacteria from the archaea.67 The bacterial 
endosymbiont has been postulated to be the origin of mitochondria by analysis of genomic 
studies. Almost all eukaryotic cells possess mitochondria which are responsible for ATP 
production by oxidative phosphorylation. Through millions of years of evolution, mitochondria 
have retained a similar core genome responsible for oxidative phosphorylation but have lost most 
of the other original bacterial genes which have been replaced by nuclear DNA.67 The 
evolutionary advantage of this adaptation is that the cell can possess thousands of mitochondria 
to produce much more energy at a fraction of the total cost.67 The oxidative phosphorylation 
pathway involves the two electron oxidation of the reduced form of nicotinamide adenine 
dinucleotide (NADH) or flavin adenine dinucleotide (FADH2) to an electron acceptor complex 
which is passed through a series of redox active complexes to ultimately reduce molecular 
oxygen to water.68 The energy gained from the electron transport chain is used to pump protons 
against its concentration gradient from the inside of the inner mitochondrial membrane to the 
intermembrane space. Consequently, a pH gradient is generated as well as a voltage gradient, 
collectively known as an electrochemical gradient.68 The enzyme, ATP synthetase can use the 
energy from this gradient to synthesize ATP from ADP by allowing the protons to flow down the 
concentration gradient back to the inside of the cell. The overall process is generally very 
efficient, however, the electrons may leak to partially reduce oxygen or other organic substrates 
such as ubiquinone or flavin to generate radicals known as reactive oxygen species like 
superoxide.68,69 As a result of electron leakage, reactive oxygen species rise, ATP synthesis 
decreases and a signal cascade ensues to either protect the cell or induce apoptosis by the release 
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of cytochrome c.67 The mitochondria may reduce electron leakage by increasing the expression 
of the protein complexes involved in oxidative phosphorylation through redox sensitive 
transcription factors.67 While the complete redox sensitive mechanisms for reducing electron 
leakage are not completely understood, the redox sensitivity may arise from reactive thiols in the 
mitochondrial proteome. For example, it has recently been revealed that the uncoupling protein-1 
(UCP-1), a protein in the mitochondria of brown fat adipose tissue, is a redox sensitive protein 
regulated by the S-sulfenylation of a key cysteine residue.70 The current efforts of the Weerapana 
group are focused on identifying reactive cysteine residues in the mitochondrial proteome.71 
Future investigation may reveal the implication of arylating tocol quinones as redox sensitive 
control in some of the mitochondrial proteins.  
 The implication of the arylating tocol quinones may not be limited to mitochondrial 
proteins. The excess formation of reactive oxygen species and electrophiles in eukaryotes may 
have profound biological effects such as the formation of DNA adducts, mutagenicity and 
membrane damage. These effects are known causes of cancer, cardiovascular complications, 
acute and chronic inflammation and neurodegenerative diseases.72 It is imperative for the human 
body to effectively manage these compounds to survive, grow, and develop.72 The Nrf2:Keap1 
pathway is considered the most important cellular response to protect the cell from oxidative and 
electrophilic stress.72,73 The expression of various enzymes which are responsible for the 
elimination of oxidants and electrophiles include: NADPH:quinone oxidoreductase 1 (NQ01), 
UDP glucuronosyltransferase (UGT) and glutathione S-transferase (GSH) all of which are 
regulated by the antioxidant/electrophile response element (ARE/EpRE) involved in the 
Nrf2:Keap1 pathway.72,73 
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 NF-E2 related factor 2 (Nrf2) is a protein that binds to the ARE/EpRE region of DNA 
and promotes expression of the antioxidant/electrophilic stress response enzymes. Under normal 
unstressed conditions, two of these proteins are bound to a Kelch-like ECH associated protein 1 
(Keap1) – Cullin3-based ubiquitin E3 ligase (Cul3) homodimer.72–74 The association of Nrf2 and 
the Keap1/Cul3 homodimer inhibits Nrf2 as a trans-acting promoter. Under conditions of 
electrophilic stress, the association between Keap1:Nrf2 is inhibited and Nrf2 synthesized de 
novo can promote enzyme expression.72–74 
The Nrf2 protein has six domains (Neh 1-6) each associated with a different property to 
achieve its overall function.73,74 The Neh1 domain is associated with binding to small Maf 
proteins and binding to the ARE recognition site. Neh 4 and 5 are related to a trans-activation 
function by recruiting co-activator proteins. Neh 6 functions as a recognition site for degradation 
by proteasomes in the cytosol. Neh 3 represents the C-terminus of the protein. Neh2 is associated 
with binding to the Keap1 homodimer. It contains an ETGE and DLG Keap1 binding motif. 
Under normal conditions, the ETGE motif binds to one monomer and the DLG motif binds to the 
other. Thus, two Nrf2 proteins can be bound per Keap1 homodimer. The ETGE and DLG 
binding motifs are separated by seven lysine residues susceptible to ubiquitination by Cul3. 
Ubiquitination tags the protein complex for degradation by proteasomes in the cytosol. 
Therefore, the function of Nrf2 as an enzyme expression promoter is inhibited.72–74 
Keap1 is a protein rich in reactive thiol groups that are susceptible to adduct formation 
with electrophiles. Cysteine 273 and cysteine 288 are exposed on the surface of Keap1 making 
them particularly susceptible to electrophiles.72–74 Electrophile adduct formation with these 
cysteine residues brings a conformational change in the structure of the Keap1-Cul3 homodimer. 
The DLG binding motif of Nrf2 has much weaker binding interactions with Keap1 than the 
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ETGE binding motif. Consequently, only the DLG binding motif dissociates from the Keap1 
complex. This is known as the hinge and latch model demonstrated in Figure 11.73 As a result, 
Cul3 activity is decreased and newly synthesized Nrf2 can activate the antioxidant/electrophilic 
response element enzymes.72–74 
 
Figure 13: The hinge and latch model of the Nrf2:Keap1 pathway. Figure taken with permission 
from Urono & Motohasi.73 
 
The endoplasmic reticulum is a highly membranous structure in the cell responsible for 
the synthesis of proteins, lipids and cholesterol.75 It is suggested that the concentration dependent 
cytotoxicity observed in cultured cells treated with arylating quinones may be due to an 
endoplasmic reticulum stress response also known as the unfolded protein response (UPR).65 The 
arylating tocol quinones may form adducts with free thiol groups of proteins being synthesized, 
in turn disrupting disulfide bond formation and proper folding. This would encourage 
endoplasmic stress and activate the UPR. The UPR slows down protein production, degrades 
misfolded proteins and increases activation of proteins involved in protein folding in an attempt 
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to remain viable.76 If these attempts do not alleviate endoplasmic reticulum stress, the UPR 
induces apoptosis.63–65,76 
 In summary, the cell contains many different thiols which may be involved in cell 
signalling pathways upon modification. The role of arylating tocol quinones in these pathways is 
of current interest. The rate of reactivity of the tocol quinones with thiols as well as the cellular 
localization and concentration of the quinones may explain the biological differences observed 
between the isoforms of vitamin E.  
 
1.6 Project Overview 
 
 To fully understand the role of the tocol quinones in cell signalling pathways, the 
reactivity of such species with model thiols needs to be established. The literature on tocol 
quinones is limited; Cornwell’s group has demonstrated the capability for GSH arylation in vitro 
by γ-tocopherol quinone but not α-tocopherol quinone. In addition, the cytotoxicity of the tocol 
quinones in various cell cultures has been assessed and the general trend in order of decreasing 
cytotoxicity is as follows: δ> γ>α.51 We propose that the cytotoxicity observed between the tocol 
quinones and differences in biological activity observed between the tocopherols is a function of 
the reactivity of the quinones towards thiols. We hypothesize a higher reactivity of δ-tocopherol 
quinone with thiols compared to γ-tocopherol quinone owing to the lack of electron donating 
methyl group in δ-tocopheryl quinone making it more electrophilic as well as less steric 
hindrance. While it might be reasonable to assume similar reactivities with the tocotrienol 
quinone, the formation of Michael adducts with thiols in the tocotrienol family is still unknown. 
There is no chemical justification for an increased rated of tocotrienol quinones, however, given 
some of the different biological effects exhibited by the tocotrienols such as the anti-cancer 
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properties mentioned earlier, it may be possible the tocotrienols quinones exhibit increased rate 
of reactivity with thiols.  
 This thesis will focus on the synthesis and reactivity of all tocochromanol quinones. The 
synthesis and reactivity of β-tocohromanol quinones is omitted owing to the similar structure and 
reactivity with γ and the limited biological relevance due to its scarcity in nature.19 Tocol 
quinones will be synthesized from the oxidation of parent congeners. The rate of reactivity of the 
tocol quinones with a model thiol like N-acetyl cysteine will be performed using UV/Vis 
spectroscopy.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
39 
 
2. RESULTS AND DISCUSSION 
 
2.1 Isolation of Vitamin E Congeners 
 
The synthesis of vitamin E quinones was performed by the oxidation of the parent tocols. 
This required pure samples of each vitamer. Silica column chromatography was the general 
technique used for separation. A vegetable oil suspension rich in tocopherols (obtained from 
Archer Daniels Midland Co.) was used to isolate pure samples of α-, γ- and δ-tocopherol. The 
components of the oil suspension are eluted in order of increasing polarity. The first fractions 
eluted from the column contain undesired non-polar lipids, mostly triglycerides, and carotenoids. 
α-Tocopherol eluted next followed by γ-tocopherol and lastly δ-tocopherol. There is a very slight 
Rf difference between the tocopherols, thus, multiple columns were required for full separation. 
The best separation was achieved using a 99:1 hexane to ethyl acetate mixture. A slow stepwise 
increase in ethyl acetate concentration increased the rate of elution, however, this came at the 
expense of decreased resolution. The crude oil contains approximately 40 % by weight γ-
tocopherol and ~15 % δ-tocopherol. The yield of α-tocopherol was not evaluated because it was 
left as impure fractions with non-polar lipids and/or carotenoids. α-Tocopherol was obtained by a 
much simpler method consisting of the hydrolysis of commercially available α-tocopherol 
acetate using potassium hydroxide in methanol.77  
A palm kernel oil suspension rich in tocotrienols obtained from Carotech Sdn Bhd. called 
TOCOMIN® was used to isolate pure samples of α-, γ- and δ-tocotrienol. The order of elution of 
the components of this oil suspension was as follows: non-polar lipids and/or carotenoids, α-
tocopherol, α-tocotrienol, γ-tocopherol, γ-tocotrienol, δ-tocopherol, δ-tocotrienol followed by 
some other unidentified oils. The degree of separation between these compounds is extremely 
minute, therefore, multiple turns of column chromatography are required using a 99:1 hexane to 
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ethyl acetate ratio, and should not exceed 9:1 hexane to ethyl acetate. The use of pressure to 
increase elution rate should be avoided as this results in greatly decreased resolution and almost 
no separation of the chief components. The sample oil should be dissolved in as little hexane as 
possible (~1-2 mL for 0.5 g of oil), the height of the sample upon loading should be minimized 
and the height of the silica in the column should be maximized for optimal separation. Typically, 
to achieve a good separation, 100 g of silica was used for 0.5 g of oil suspension in a column 
with an internal diameter of 24 mm and 40 cm in length. Approximately 2 g of each α-, γ-, δ-
tocotrienol were obtained from a 25 g oil suspension. The mass yield percentage was not 
obtained due to incomplete separation in various fractions, which were stored for future 
purification.   
  
2.2 Synthesis of Vitamin E Quinones  
 
The general oxidative strategy employed for the synthesis of tocol quinones in vitro is 
shown in Scheme 2. The use of transition metals complexes of high oxidation potential presents 
a potentially useful tool for the oxidation of parent tocols to their respective quinones. The 
successful oxidation of α- and γ-tocopherol to their respective quinones by FeCl3 has been 
reported.63–65 The synthesis of δ-tocopherol has been reported using AgNO3 as an oxidizing 
agent to prevent overoxidation.63 In 2014, we had successfully synthesized α-tocopherol quinone 
using FeCl3 in a ~50% yield (unpublished result). This same method was attempted using γ-
tocopherol but this failed to produce γ-tocopherol quinone, however this was not extensively 
investigated. We sought more efficient means of preparation of the quinones. It has been 
reported that various oxygenated aromatics like phenols, hydroquinones, methoxyphenols, and 
dimethoxybenzenes could be oxidized to the corresponding quinone using a silica-supported 
oxidation with ceric ammonium nitrate (CAN, (NH4)2Ce(NO3)6) in good yields.
78 Typically, the 
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reagent is used in aqueous acetonitrile, but the silica-supported method increases reaction rates 
and yields, eliminates the wastewater contaminated with cerium, and a simple filtration removes 
excess reagents and by-products.78 A variety of 4-methoxyphenols derivatives were reported to 
be converted to the corresponding quinone in yields of 87% or higher.78 Cerium (IV) lanthanide 
complexes are efficient oxidants owing to a high redox potential of ~1.61 V.79  Cerium (IV) is 
generally prepared as ceric ammonium nitrate salt because it is relatively non-toxic, easy to 
handle and stable.79 Upon oxidation of electron-rich aromatics, cerium (IV) is reduced to cerium 
(III) in a one electron transfer, therefore, two equivalents of CAN are required for the complete 
two electron oxidation of tocopherols to the quinones.  
4-Methoxyphenols represent a good model system for tocols. A second attempt at the 
oxidation of γ-tocopherol was performed using the solid-supported ceric ammonium nitrate 
method. The reaction was monitored by TLC and showed that after 15 minutes starting material 
had disappeared and two products had been produced. The reaction was performed multiple 
times. The products were separated by silica column chromatography. The first product to elute 
off the column was identified as ortho-γ-tocopherol quinone also known as tocored.49 This 
product was isolated in a ~25% yield and the common name (tocored) given to this compound 
reflects its bright red oily appearance. The second product to elute off the column was a bright 
yellow oil identified as para-γ-tocopherol quinone. The product was isolated in a ~50% yield. 
The last 25% was left at the top of the column but was not isolated. This silica-supported CAN 
oxidation of parent tocols presents a simple synthesis of tocol quinones. Accordingly, the same 
procedure was repeated for the other tocol isoforms and similar results were obtained. The α-
tocopherol and α-tocotrienol isoforms yielded only one product identified as the corresponding 
para-α-tocopheryl and para-α-tocotrienyl quinones in ~80% yield. It should be noted that no 
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degradation had been observed in the para-tocol quinones stored as an oil in the fridge at 4℃ 
after ~20 months. However, the ortho-tocopheryl quinones seem far less stable and may form 
dimers or degradation products upon storage in the same conditions. This effect is more apparent 
in the ortho-δ-tocopheryl quinones.  
 Methods aimed towards the selective synthesis of the ortho- or para-quinone were not 
explored in this investigation. In this procedure, tocols dissolved in DCM were added to a slurry 
of CAN loaded silica stirring in DCM at room temperature. This procedure offers several 
parameters that can be altered and may produce different ratios of ortho- to para-quinones. 
Firstly, the order of addition can be changed. By adding the tocols to the slurry of CAN, there is 
a great excess of CAN initially, which impacts the ratio of ortho- to para-quinones. Adding the 
slurry of CAN loaded silica slowly to a solution of tocopherol would avoid the large excess of 
CAN initially in the original procedure. Secondly, the effects of solvent polarity on the ratio of 
ortho- to para-quinones can be explored. Thirdly, the ratio of CAN to silica can be changed 
which would have similar implications to the order of addition described above. In addition to 
providing a solid support for CAN, silica is also slightly acidic, so the amount of silica may also 
have an impact on the reaction yields. Lastly, the effect of temperature on the product ratio can 
also be explored. Failing these attempts, Saladino et al. have reported the efficient synthesis of 
quinones from parent tocopherols using a methyltrioxorhenium hydrogen peroxide (MTO/H2O2) 
catalytic system. Additionally, they have reported the ability to obtain different ratios of ortho- to 
para-quinones based on different polymer supported MTO/H2O2 catalysts.
80 The use of this 
catalyst was not explored in this investigation. 
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Scheme 2: General scheme for the synthesis of tocol quinones from their parent quinones  
 
 
2.3 The Synthesis of Quinone Thiol Adducts  
 
 The main goal of this project was to measure the rate of reactivity of the tocol quinones 
with a model thiol such as N-acetyl cysteine (NAC) using UV/Vis absorption spectroscopy. The 
initial attempts to monitor the reaction of γ-tocopherol quinone with NAC seen in Scheme 3 
were performed in ethanol. There were no changes in absorption spectra observed after 8 hours 
upon the addition of a solution of NAC dissolved in ethanol to a solution of γ-tocopheryl quinone 
dissolved in ethanol. The lack of changes observed in the absorption spectra could indicate one 
of two things: either there was no reaction occurring, or the product has the same absorption 
spectrum as the starting material.  
 
Scheme 3: The proposed mechanism of thiol addition to quinone derivatives.   
 
At first, we proposed that the UV/Vis spectrum of α-tocopheryl hydroquinone may be a 
good model of the γ-tocopheryl hydroquinone NAC conjugate. The synthesis of α-tocopherol 
hydroquinone was attempted using excess NaBH4 in a solution of methanol. Interestingly, the 
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yellow solution became clear but reverted to the yellow color within two minutes. It was 
hypothesized that NaBH4 efficiently reduced the quinone to the hydroquinone which was then 
readily oxidized back to the quinone by atmospheric oxygen. To confirm this hypothesis, the 
reduction of α-tocopheryl quinone with NaBH4 was monitored by UV/Vis absorption. The 
absorption spectra seen in Figure 12 show the changes in absorption spectra upon the reduction 
of α-tocopheryl quinone with NaBH4. After three hours, the UV/Vis absorption spectrum 
reverted to that of the original α-tocopheryl quinone, suggesting a re-oxidation by oxygen had 
occurred. As such, the α-tocopheryl hydroquinone product could not be isolated. 
 
 
 
 
 
 
 
 
 
Figure 12: The UV/Vis absorption spectral changes of α-tocopherol quinone with the addition of 
NaBH4. 
 
It became apparent that a synthetic standard of the γ-tocopheryl hydroquinone NAC 
adduct was required to identify the UV/Vis absorption spectrum properties. The reaction of γ-
tocopheryl quinone with NAC was attempted in ethanol in a round bottom flask while 
monitoring by TLC using a 4:1 hexane to ethyl acetate ratio. After stirring for twelve hours at 
room temperature, most of the starting material appeared to remain unreacted, although a spot on 
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the baseline was visible. It was assumed that no reaction had occurred and the spot on the 
baseline was an oxidized degradation product. This was a surprising result given the successful 
synthesis of γ- and δ-tocopheryl hydroquinone glutathione adducts previously reported.63,64 To 
validate the unsuccessful synthesis of the γ-tocopheryl hydroquinone NAC adduct observed in 
our laboratory, the reaction was attempted using the same conditions we previously tried but 
with a theoretically more reactive quinone: p-benzoquinone. The benzoquinone is expected to be 
more reactive owing to its lack of electron donating groups and lack of steric hindrance. The full 
conversion of benzoquinone starting material to the NAC-adduct was observed by TLC to be 
complete after twelve hours, and only one spot was observed on the baseline using a 4:1 hexane 
to ethyl acetate ratio. A solvent ratio of 9:1:0.1 (ACN:MeOH:HOAc) was required to resolve the 
spot on the TLC sheet, which showed only one spot with a Rf of about 0.1. The product was 
isolated by column chromatography using the same 9:1:0.1 (ACN:MeOH:HOAc) solvent ratio 
and was identified as a p-benzohydroquinone mono-NAC adduct by 1H NMR and electron 
ionization mass spectrometry (MS/EI) (Figure 13).  
 
Figure 13: The structure of the p-benzohydroquinone mono-NAC adduct. 
 
While the reaction yielded the desired quinone-thiol conjugate, the reaction rate was too 
sluggish (~24 hours) to monitor rates of reaction within an ideal timeline (minutes).  To improve 
the rate of reaction, the reaction was performed under more basic conditions to promote the 
formation of the more nucleophilic thiolate. The pKa of the side chain thiol of L-cysteine is 
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around 8.7,81 therefore NAC was dissolved in a Tris/HCl buffer at pH 8.5 to increase the percent 
ionization (~50%). This was added to a solution of benzoquinone dissolved in methanol. A 
change in color from yellow to orange happened almost immediately and the starting material 
was consumed in less than five minutes as demonstrated by TLC. The product from this reaction 
was identified as the same adduct obtained previously in methanol and in similar yields (~75%), 
however the rate of reaction was drastically improved. Next, the successful synthesis of a 2,3,5-
trimethylhydroquinone NAC adduct was achieved using these solvent conditions. Consequently, 
the methanol and Tris/HCl buffer solvent system appeared to be a good option for the synthesis 
of the γ-tocopheryl hydroquinone NAC adduct.  
 Accordingly, the reaction of γ-tocopherol quinone with NAC was re-evaluated using the 
methanol and Tris/HCl buffer (pH 8.5) solvent system. A change in color of the solution from 
yellow to orange occurred after 15 minutes. The complete conversion of the γ-tocopherol 
quinone was demonstrated by TLC (hex/EtOAC 4:1) and only one spot on the baseline was 
visible. This spot was isolated as one product using the 9:1:0.1 (ACN:MeOH:HOAc) solvent 
system. The product was hypothesized to be the desired γ-tocopheryl hydroquinone NAC adduct 
obtained in a 75% yield after isolation. The adduct was characterized by 1H NMR, 13C NMR, IR, 
UV/Vis absorption spectroscopy and electrospray ionization mass spectrometry (ESI-MS). The 
1H NMR and ESI-MS spectra were consistent with the predicted spectra for γ-tocopherol 
hydroquinone NAC adduct. However, the peaks at 184.12 ppm and 182.97 ppm in the 13C NMR, 
and the lack of ν(OH)(s) between ~3600-3100 cm-1 in the IR spectrum, were indicative of a 
quinone species. Furthermore, the UV/Vis absorption spectrum of this compound showed two 
peaks (λmax = 267 nm, ε = ~2,200 M-1•cm-1, λmax = 307 nm, ε = ~1,700 M-1•cm-1), which 
resembles the spectrum of a quinone. Khalife and Lupidi have previously monitored the reaction 
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of thymoquinone with glutathione (GSH) by UV/Vis spectroscopy. The absorbance for the 
original thymoquinone showed an absorbance maxima at 257 nm and an absorbance maxima at 
303 nm for the thymohydroquinone GSH adduct.82 Therefore, we hypothesized that the γ-
tocopheryl hydroquinone NAC adduct was actually oxidized to a γ-tocopheryl quinone NAC 
adduct in the presence of oxygen. To test this hypothesis, NaBH4 was added to a solution of the 
γ-tocopheryl quinone NAC adduct dissolved in ethanol. Similarly to the synthesis of α-
tocopherol hydroquinone, the yellowish-orange solution turned clear then reverted to the 
yellowish-orange solution in the presence of air. The change in color was monitored by UV/Vis 
spectroscopy. The absorption spectrum of the starting material showed two peaks (λmax = 267 
nm, ε = ~2,200 M-1•cm-1, λmax = 307 nm, ε = ~1,700 M-1•cm-1). Upon the addition of NaBH4 the 
peak at 267 disappeared and the peak at 307 was increased (307 nm, ε = ~2,400 M-1•cm-1). After 
exposure to air for three hours the spectrum reverted to that of the original spectrum as seen in 
Figure 14. Consequently, the reactions of tocol quinones with NAC should be monitored in the 
absence of air. To overcome this obstacle, we secured the UV/Vis spectrophotometer in a two-
hand zipper lock Aldrich® Atmosbag with a nitrogen inlet and vacuum outlet that allowed for the 
exclusion of oxygen. The apparatus is depicted in Figure 15. 
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Figure 14: The UV/Vis absorption spectral changes of γ-tocopherol quinone NAC adduct (0.17 
mM in MeOH) with NaBH4. 
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Figure 15: The apparatus used to exclude atmospheric oxygen to monitor the of the rates of 
reaction of the tocopheryl quinones with NAC by UV/Vis spectroscopy. The UV/Vis 
spectrophotometer is inside the bag with the necessary reagents for the reaction and the bag was 
filled with N2 gas. 
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2.4 Tocol quinone reactivity with N-Acetyl Cysteine  
 
2.3.1 Stoichiometry of the reaction 
 The rate of reaction of tocol quinones with NAC was monitored by following the increase 
in absorption at 308 nm from the formation of the tocol hydroquinone-NAC adduct. It has 
previously been reported that the reaction of a naphthoquinone derivatives in the absence of 
oxygen proceeds through a reaction mechanism with the overall stoichiometry of two quinones 
for each thiol.83 This was demonstrated by titrating the quinone with increasing equivalents of 
thiols which showed a maximum absorbance after the addition of 0.5 equivalents of thiol. The 
authors reported that the rate limiting step is the addition of the thiolate anion to the quinone. The 
resulting hydroquinone adduct is oxidized to a naphthoquinone adduct via a fast two electron 
comproportionation reaction reducing another equivalent of starting naphthoquinone to the 
naphthohydroquinone. The naphthohydroquinone is no longer reactive towards thiols, therefore 
two equivalents of naphthoquinone are consumed for each thiol.83  
 Therefore, we investigated the stoichiometry of reaction of γ-tocopheryl quinone with 
NAC using a similar method reported above. The absorbance at 308 nm was recorded following 
the sequential addition of twenty aliquots consisting of 0.1 mol equivalents of NAC. It can be 
seen in Figure 16 that the maximum absorbance occurred at around one equivalent of NAC. 
There is a slight increase in absorbance observed after one equivalent of thiol. This is a product 
of residual quinone in solution which is slowly reacting when additional thiol is added. This 
limitation may be avoided by allowing longer times between additions of thiols. Nonetheless, 
this would indicate a one-to-one ratio of thiol to γ-tocopherol quinone in the formation of the γ-
tocopheryl hydroquinone adduct. This suggested that the comproportionation reaction previously 
reported with naphthoquinone GSH adducts does not occur in our system. The rate of 
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comproportionation is directly influenced by the electron density in the aromatic moiety of the 
hydroquinone, that is, the rate of comproportionation is increased as electron density decreases.84 
The increased electron density of tocopheryl quinones compared to naphthoquinones may 
explain the failure to observe comproportionation in our system. In a previous study, the effect of 
electron density on a quinone/hydroquinone system on the rates of comproportionation was 
explored.85 The rates of comproportionation drastically decreased as electron withdrawing 
groups were added and drastically increased as electron donating groups were added.85 
 
Figure 16: The titration of γ-tocopheryl quinone with NAC in a solvent system of 67% 
methanol/33% Tris buffer (pH8.5) by following the maximum absorbance at 308 after the 
addition of each aliquot. Concentrations after mixing were 74 µM γ-tocopheryl quinone, with 
NAC in the range of (0-147 µM). The reaction was monitored with a spectrophotometer that had 
been placed inside a N2-purged glove bag.  
 
2.3.2 Effect of solvent system on the rate of reaction  
 The first attempts at monitoring the rate of reactivity of γ-tocopherol quinone with NAC 
were done in a solvent system of 67% methanol/33% Tris buffer (pH 8.5) simply because it was 
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an easy solvent system and ratio to work with experimentally. Methanol was an attractive solvent 
for the organic solvent because it most closely resembles the properties of water in terms of its 
polarity and hydrogen bonding capabilities out of the most commonly used organic solvents. Its 
lower boiling point compared to ethanol was also an attractive feature since the quinone sample 
solutions were first evaporated prior to placing in the glove bag. The 67% methanol to 33 % Tris 
buffer was also easiest to manipulate in a 3-mL cuvette, however, the effect of the solvent system 
on the rate of reaction was of interest. The rates of reaction were recorded by following the 
increase in absorbance at 308 nm over time as seen in Figure 17. The effect of the solvent 
system on the rate constants (k) from curves fit to a one-phase exponential using Prism software 
are shown in Table 7. It was clear that the more aqueous the solvent-system was, the greater the 
rate constant was for the addition of NAC to the quinone. Furthermore, the rate of reaction was 
much slower at 67% iso-propanol compared to 67 % methanol. This would suggest that an 
increase in solvent polarity corresponds with an increased reaction rate. However, a certain 
concentration of organic solvent is required for the reaction to occur as demonstrated by the 
absence of reactivity observed in the reaction with 10% methanol. The organic solvent is 
required for the solubility of the quinones. The rate of reaction was fastest at 50% methanol, 
although a much greater error was observed and the fit to the one-phase association curve was 
less than optimal with an R2 value of 0.3693. Together, these data suggest that the 67% 
methanol/33% aqueous buffer is an ideal solvent to assess and compare the reactivity of the other 
tocol quinones with NAC.  
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Figure 17: The effect of solvent conditions on the rate of reactivity of γ-tocopherol quinone 
(0.074 mM) with two equivalents of NAC using 100 mM Tris/HCl at pH 8.5 as the aqueous 
buffer.  
 
Table 7: The extracted rate constant of the reaction of γ-tocopherol quinone with NAC fit to a 
one-phase association curve. The buffer consisted of 100 mM Tris/HCl aqueous buffer at pH 8.5. 
Two equivalents of NAC were used.  
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67% MeOH/33% buffer 0.1301 ± 0.0009 0.9981 
58% MeOH/42 % buffer 0.185 ± 0.002 0.9975 
50% MeOH/50% buffer 3.1 ± 0.4 0.3693 
10% MeOH/90% buffer - - - 
67% Iso-Propanol/33% buffer 0.0480 ± 0.0002 0.9993 
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2.3.3 The effect of oxygen on the reactivity  
 To measure the rate of reaction of the tocol quinones with NAC the reactions were 
performed under nitrogen atmosphere to prevent the oxidation of the hydroquinone adduct to a 
quinone adduct. The importance of excluding oxygen was demonstrated in a reaction with γ-
tocopherol quinone and NAC in the presence of air. The absorbance was recorded at 308 nm 
over time which is depicted in Figure 18. The absorbance increased steadily in absorbance for 
the first few minutes indicating the formation of the γ-tocopheryl hydroquinone-NAC adduct. 
However, at around ten minutes, a steady decrease in absorbance is observed. The oxidation of 
the hydroquinone adducts to quinone adducts by oxygen is responsible for this effect. As such, 
the importance of excluding oxygen from the reaction conditions was established. 
 
Figure 18: The reactivity of γ-tocopherol quinone (74 µM) with NAC (148 µM) at 67% 
MeOH/33% Tris HCl (pH 8.5) in the presence of air.  
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2.3.4 The rate of reactivity of tocol quinones with NAC  
 Figures 19 (A-L) shows the change in absorption spectra over time of the various tocol 
quinones after the addition of N-acetyl cysteine. The changes in the absorption spectra for γ-
tocopherol quinone are almost identical to the changes observed in the spectra of the γ-
tocotrienol quinone. As seen in Figure 19 (A-F) (γ-T and γ-T3 at pH 8.5, 7.5 and 6.5), the 
addition of NAC resulted in a progressive decrease in the absorbance at 260 nm and a 
progressive increase in the absorbance at 307 nm. The decrease in the absorbance at 260 nm is a 
result of the loss of tocol quinone which is being converted to the NAC-hydroquinone adduct. 
Consequently, the increase in the absorbance peak at 307 nm is a result of the formation of the 
NAC hydroquinone adduct. There are two points where the absorbance does not change over 
time, these are known as isosbestic points and they occurred at 241 nm and 281 nm; this suggests 
that the quinones were being converted to a single product. It should be noted that the initial 
absorption spectra at 0 minutes does not pass directly through the isosbestic points because the 
spectra were recorded prior to the 1 mL addition of NAC in aqueous buffer. The changes in 
absorption spectra of δ-tocopherol quinone are almost identical to the changes observed in δ-
tocotrienol quinone after the addition of NAC. As seen in Figure 19 (G-L) (δ-T and δ-T3 at pH 
8.5, 7.5 and 6.5), the addition of NAC resulted in a progressive decrease in the absorbance at 257 
nm and a progressive increase in the absorption at 303 nm as a result of the conversion of the 
tocol quinone to the NAC hydroquinone adduct. There are two isosbestic points at 239 nm and 
279 nm suggesting the conversion of the quinones to one single product. 
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Figure 19 (A-L): The change in absorption spectra over time of the various tocol quinones (74 
µM) after the addition of 4 eq. of N-acetyl cysteine in a solvent system of 67% MeOH/ 33% 
aqueous buffer at the pH stated. 
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The rates of reactivity of the various tocol quinones with NAC were recorded by 
following over time the formation of tocol hydroquinone NAC adduct which has a maximum 
absorbance at 308 nm. The reactions were performed under nitrogen atmosphere in 67% 
methanol/ 33% aqueous buffer. The rates of reactivity were assessed for each quinone at three 
different pHs: 8.5. 7.5 and 6.5. The average of three trials for each quinone was fit to a single 
exponential curve is shown in Figures 20-22. The curves were fit to both a one- and two-
exponential equation. The single exponential equation was Y=Y0 + (Ymax-Y0) (1-e
(-kx)) and 𝑌 =
𝑌𝑚𝑎𝑥1(1 − 𝑒
−𝑘1𝑥) +  𝑌𝑚𝑎𝑥2(1 − 𝑒
−𝑘2𝑥)  for the double exponential from the software GraphPad 
Prism where Y is the absorbance values, “plateau” is the same as Ymax, and x is time in 
minutes. The fit for both curves were excellent but we have no chemical reason to justify a 
double exponential which would be required if there were two simultaneous rates, one fast and 
one slow. The extracted rate constants (k) from single exponential fits of the data can be seen in 
Table 8. As expected, the rate constants increased as the pH increased for all the non α-tocol 
quinones which is also depicted in Figure 23. This is a result of the enhanced nucleophilicity of 
a thiolate anion compared to the neutral thiol. In addition, a significant difference in the rate of 
reactivity was observed; the rate of reactivity decreases from δ > γ>>>α (α = 0). The rate of 
reactivity was significantly faster for the δ-tocol quinones than for the γ-tocol quinones whereas 
the α-tocol quinones did not react. This agrees with our original hypothesis that the rate of 
reactivity of the quinones with NAC is a function of the substitution pattern on the chromanol 
ring. However, in contrast to our original hypothesis, there does not appear to be a significant 
difference between the reactivity of tocopheryl quinones and tocotrienyl quinones with the same 
substitution pattern on the chromanol ring. Therefore, it may be possible that the differences 
observed in biological assays between the tocopherols, such as the ones seen earlier in Figure 9 
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and Figure 10, are a function of the rate of reactivity of the respective quinones with thiols. This 
data may also present an evolutionary reason for the preferential retention of α-tocopherol but a 
significant difference between the tocotrienols is still not established. To investigate further into 
this matter, we sought to investigate the redox properties of the tocols and their respective 
quinones using cyclic voltammetry (CV).    
 
Table 8: The extracted rate constants of the reactions of tocol quinones with NAC fit to a one-
phase association curve at three different pHs. The trials were done in triplicates. Four 
equivalents of NAC were used. 
 pH 8.5 (100 mM Tris/HCl) pH 7.5 (100 mM Tris/HCl) pH 6.5 (100 mM bis-Tris/HCl) 
Compound k 
(min-1) 
Std. Err. R2 k 
(min-1) 
Std. Err. R2 k 
(min-1) 
Std. Err. R2 
α-TQ - - - - - - - - - 
α-T3Q - - - - - - - - - 
γ-TQ 0.160 0.003 0.981 0.083† 0.002 0.958 0.00684 0.00002 0.9921 
γ-T3Q 0.134 0.001 0.995 0.0861† 0.0002 0.9992 0.00595 0.00002 0.9926 
δ-TQ 5.81‡ 0.32 0.98 0.63' 0.01 0.99 0.0621 0.0007 0.9066 
δ-T3Q 4.84‡ 0.26 0.96 0.63' 0.02 0.96 0.0775 0.0005 0.9883 
Note: † ‡ ' symbols designate rate constants that are not significantly different at the 95 % 
confidence interval 
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Figure 20: The rate of reactivity of tocol quinones (74 µM) with four equivalents of NAC in a 
solvent system of 67% MeOH/ 33% Tris/HCl buffer at pH 8.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21: The rate of reactivity of tocol quinones (74 µM) with four equivalents of NAC in a 
solvent system of 67% MeOH/ 33% Tris/HCl buffer at pH 7.5 
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Figure 22: The rate of reactivity of tocol quinones (74 µM) with four equivalents of NAC in a 
solvent system of 67% MeOH/ 33% bis-Tris/HCl buffer at pH 6.5 
 
 
 
 
Figure 23: The effect of pH on the rate of reactivity of γ-tocopherol quinone (74µM) with four 
equivalents of NAC in a 67% MeOH/ 33% aqueous buffer solvent system. Similar effects are 
observed for all non α-tocol quinones. 
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Figure 24: The the rate of reactivity of γ-tocopheryl quinone (74 µM) and γ-tocotrienyl quinone 
(74 µM) with four equivalents of NAC in a 67% MeOH/ 33% aqueous buffer solvent system.  
 
 
       2.3 Tocol and Tocol Quinone Redox Activity 
 
 In this study, we have demonstrated the rate of reactivity of the tocol quinones with a 
model thiol at various pHs. It was observed that the δ-tocol quinone isoforms react much quicker 
than the γ-tocol quinones whereas no reactivity was observed with the α-isoforms. In contrast to 
our hypothesis, there was no significant difference in reactivity observed between the 
tocopherols and tocotrienols with the same chromanol methylation pattern. We suggest that this 
may explain the differences observed between the tocols with different methylation patterns in 
biological assays, however, it does not explain the differences observed between tocopherols and 
tocotrienols. Furthermore, in most cell culture assays and in vivo assays, the cells and animals are 
supplemented with the tocols and not the quinones, which complicates the issue, as any oxidation 
of the tocols to their respective quinones may occur at substantially different rates. 
As mentioned previously, Christen et al. studied the inhibition of peroxynitrite and SIN-1 
induced PC liposome hydroperoxide formation by α- and γ-tocopherol.49 In these experiments, it 
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was found that α-tocopherol was oxidized almost quantitatively to α-tocopherol quinone (90%) 
and γ-tocopherol formed an oxidized ortho-γ-tocopherol quinone product called tocored (~25%), 
5-nitro- γ-tocopherol derivative (50%) and 25% remained unreacted.49 Although these studies 
suggest the formation of quinones in biological assays, it is rather concerning that much of the 
literature on tocols in cell culture assays do not look for the formation of quinones after the 
assay. For instance, in the experiments mentioned earlier by McCormick and Parker, cell lines 
were incubated with various tocopherols for up to 48 hours.51 The general trend observed was 
that δ-tocopherol was more cytotoxic than γ-tocopherol whereas α-tocopherol was not cytotoxic. 
However, the cytotoxic effects were not observed in two out of the six cell lines tested and the 
authors attributed this to a lower accumulation of the tocopherols in these two cell lines. Based 
on their ability to metabolize tocopherols and their reduced cellular uptake of tocopherols, the 
authors chose to examine the resistant hepatocyte cell line HepG2 for water-soluble tocopherol 
metabolites.51 It was observed that greater than 90% of the tocopherols were recovered in the 
combined medium and cell extracts, thus, the difference in cellular uptake of tocopherols could 
not be explained by increased metabolism. Still, the authors did mention that no cytotoxic effects 
were observed despite forcing the cellular concentration in the “resistant” cell lines to be as high 
as in the other cell lines. Therefore, this suggested that another mechanism other than the cellular 
accumulation must be taking place, although the mechanism is unclear. It is plausible that the 
cytotoxicity is a function of the oxidative status in the different cell lines which may form 
quinones in the non-resistant cells and remain as tocopherols in the resistant cell lines. The 
studies mentioned earlier by Elisia and Kitts, which demonstrated the difference in the ability for 
different tocopherol isoforms to modulate the Nrf-2 and Nf-κB pathways, also refrained from 
identifying the quinones even after incubating in IFNγ/PMA induced pro-inflammatory oxidative 
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conditions of Caco-2 cells for 24 hours.52 Given the highly oxidative conditions of these cells, it 
would not be surprising that the effects observed in these experiments are a result of the 
formation of the quinones. The studies mentioned earlier performed by Yu et al. showed the 
tocotrienols to be more effective at inducing apoptotic properties in two human breast cancer cell 
lines after incubation for 3 days. The authors did not mention any recovery of the tocols and 
made no attempt at identifying any quinones. Therefore, it is possible that the tocols in the cells 
were oxidized to the quinones and the effects observed are a property of the quinone products. 
There are various reports of cell culture assays supplemented with the various tocols in the 
literature that fail to make any attempts at identifying the quinones or even recovering the tocols 
after long incubation periods in the cells. Furthermore, the effects seem to be cell specific which 
may be a result of the concentration of quinones governed by the oxidative status of the cell.  
Thus, we are suggesting that the different effects observed with the tocols is the result of 
the formation of the quinones and different reactivities between these quinone products, and not 
the antioxidant ability of the tocols themselves. Since there is no significant difference in 
reactivity with thiols between the tocotrienol quinones and the tocopherol quinones with the 
same methylation pattern, it is plausible that there are differences in other properties of tocols 
and their quinones. These properties may include: the ease of forming the quinones in the first 
place, a difference in the redox properties of the quinones, or the biological behavior of the 
tocols in membranes (depth, mobility or intermembrane-transfer rates).34,43,47 It has been 
demonstrated that α-tocotrienol was more readily transferred between membranes than α-
tocopherol and that α-tocopherol increased the rigidity of the membrane compared to α-
tocotrienol.47 Therefore, our attention was turned towards identifying differences in the first two 
properties across the tocol family and their quinones.   
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Cyclic voltammetry (CV) is a technique that has been applied by organic chemists for 
more than five decades for various purposes such as studying reaction pathways or 
electrochemically generated free radicals.86 Briefly, CV measures the current generated in a 
working electrode immersed in a solution of the analyte by applying a ramping potential up to a 
predetermined potential where the applied potential is then reversed to the starting potential.86,87  
The current is measured using three electrodes: a working electrode, a reference electrode and an 
auxiliary electrode.87 The working electrode is used to remove electrons from the analyte if a 
positive potential is applied resulting in an oxidation, or provide electrons to the analyte if a 
negative potential is applied resulting in a reduction. The electrons provided to or removed from 
the analyte generates a current through the working electrode. The reference electrode maintains 
a constant potential, therefore the current passing through the working electrode can be 
compared to the reference electrode. The auxiliary electrode is required to complete the circuit 
for the electrons. In theory, the reference electrode could also be used as an auxiliary electrode, 
however this would require a current to pass through it which would disturb the constant 
potential required the reference electrode.87 The current generated through the working electrode 
is plotted against the applied potential to generate a cyclic voltammogram seen in Figure 24. The 
cyclic voltammogram in Figure 24 demonstrates the oxidation potential of ferrocene in dry 
DCM at a scan rate of 100 mV per second, which is generated from applying a positive potential 
at the working electrode to promote the oxidation of ferrocene to the ferricenium ion. The current 
is reversed at the switching potential of 1200 mV where the ferricenium ion begins to be reduced 
back to ferrocene in a reversible process. It is common practice to report the average potential of 
the forward and reverse peaks as a formal reduction potential (Eo') for the redox couple in 
reversible processes.86 A peak with a positive current is called the cathodic peak (Epc) whereas a 
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peak with negative current is termed the anodic peak (Epa).
87 The formal reduction potential can 
be applied to determine the potential necessary to oxidize or reduce an analyte. A reversible 
electrochemical process is generally defined as an electron transfer reaction so fast that the 
oxidized and reduced species maintain an equilibrium at the electrode surface. In other words, 
the electrochemistry at the electrode surface is happening before any appreciable homogeneous 
reactions in solution can occur.86 If the relationship is completely reversible, the difference 
between peaks (ΔEp) is around 58 mV per electron, however, this has been shown to vary 
significantly depending on the electron transfer rate between the analyte and the electrode, and 
on the scan rate.86 A cyclic voltammogram with larger peak separation is commonly referred to 
as quasi-reversible processes.86 The voltammogram of ferrocene shown in Figure 24 has a peak 
separation of about 280 mV which is significantly greater than the 58 mV separation of 
reversible processes. However, it is well known that ferrocene is oxidized to the ferricenium ion 
in a completely reversible one electron process, therefore ferrocene is generally used as an 
internal standard to compensate for the variance in peak separation.88,89 The formal reduction 
potential obtained from the cyclic voltammogram of ferrocene seen in Figure 24 is about 0.57 V 
Vs. Ag wire.  
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Figure 25: The cyclic voltammogram of ferrocene (2.3 mM) at a scan rate of 100 mV/s in the 
direction of the arrows with a switching potential of 1200 mV in dry DCM vs Ag wire with 77 
mM tetrabutylammonium hexafluorophosphate as the electrolyte. The arrows indicate the 
direction of the sweeping potential. The current generated in the forward direction is from the 
oxidation of ferrocene to the ferrocenium cation and the negative current in the reverse direction 
is from reduction of the ferrocenium cation to ferrocene. The process is described as reversible 
with a peak separation of ~0.28 V and oxidation potential of around 0.57 V vs Ag wire.  
 
Since the formation of the quinone from the parent tocol is an oxidative process, the use 
of cyclic voltammetry should provide insights into the ease of forming the quinones. 
Furthermore, the reduction of the quinones can also be investigated as they are redox active. The 
use of cyclic voltammetry will provide insight into the redox behavior of the quinones. The 
electrochemistry of the tocopherols has been described in various experiments using cyclic 
voltammetry and digital simulations.90–93  
The electrochemical behaviors of the tocopherols are relatively complex due to 
heterogeneous electron transfer at the electrode surface followed by homogeneous chemical and 
electron transfer reactions in solution. Even more complex behavior is observed when water is 
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present as seen in Figure 26.91 In general, the tocopherols can undergo two one-electron 
oxidations to form a phenoxonium cation. The first oxidation is a one-electron transfer which 
generates a tocopheroxyl radical cation.90–93 The subsequent loss of a proton generates a 
resonance stabilized tocopheroxyl radical which can be further oxidized to a phenoxonium 
cation. The phenoxonium quickly reacts with water to form the corresponding quinone.91 
Overall, the oxidation of the tocopherol to the quinone is the loss of two electrons and two 
protons (-2e-/-2H+) with the addition of water. The formal oxidation potential of the first electron 
for the tocopherols is ~500 mV vs ferrocene, but increases progressively as the degree of 
methylation on the chroman ring decreases.90,93 This is demonstrated in Table 9 where the α-
tocopherol analogue with a only a methyl group at C-2 instead of the phytyl chain (CH3)α-TOH, 
had the lowest formal redox potential at +0.50 ± 0.05V which progressively increases to 0.65 ± 
0.05 V with (CH3)δ-TOH.93 The methyl group derivative was used instead of the natural 
tocopherols with the phytyl chain because the side chain was previously shown to not 
significantly impact the electrochemical behavior of the tocopherols.93 This would suggest that 
the α-tocopherol is the easiest to oxidize forming the phenoxonium cation. However, another 
major difference between the tocopherols lies in the stability of the phenoxonium cation, where 
α- is stable for hours, β- for minutes and γ- and δ- for less than 1s.94 The rate constants of the 
reaction of the phenoxonium with water to form the hemiketal have been calculated using digital 
simulations of CV data and have shown a slight increase in the rate when decreasing the 
methylation pattern in the order of (CH3)α- < (CH3)γ- ≈ (CH3)δ-TOH.90 The rate constant for the 
ring opening isomerization of the hemiketal was similar across all tocopherol derivatives.90 
Together this data would suggest that although, α-tocopherol may undergo a reversible two-
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electron oxidation more easily than the other isoforms, the phenoxonium cation generated is 
more stable to hydrolysis than the other isoforms.90  
Table 9: The formal reduction potential of the tocopherols obtained by digital simulation of CV 
dataa for the two one-electron oxidation processes of tocopherols to the phenoxonium cation.90  
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Figure 26: Electrochemical oxidation mechanism of α-tocopherol in acetonitrile determined 
over a range of scan rates and water concentrations. Figure adapted from Tan et al.91  
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To the best of our knowledge the electrochemical behavior of the tocotrienols has not 
been established using cyclic voltammetry. This may have been influenced by the earlier 
observation that no significant differences in the electrochemical behavior were observed when 
the phytyl chain of tocopherol was replaced by a methyl group.90 It was concluded that the tail 
was not important in the electrochemistry, however, it may be possible that the unsaturated chain 
of tocotrienols imparts different electrochemical behavior than the tocopherols. We report here 
the cyclic voltammograms of the tocopherols and tocotrienols under the same conditions to make 
a comparison between the tocopherols and tocotrienols. The cyclic voltammograms of the tocols 
are shown in Figures 26-28 and the extracted data is compiled in Table 10.  
The behavior is similar for all compounds showing what appears to be two one-electron 
oxidation processes which would suggest the presence of a phenoxonium species. It appears that 
the first oxidation is quasi-reversible whereas the second oxidation is irreversible. More 
experiments at different scan rates, concentrations and concentrations of water may provide 
kinetic parameters that confirm the data presented here such as identifying the lifetime of the 
phenoxyl radical and phenoxonium cation.93 However, we decided that there was no compelling 
need to devote further effort on this topic. We observed the same trend of decreased redox 
potential with an increasing degree of chroman methylation as seen in the literature, where α-
tocols had the lowest oxidation potential (~ +0.3 V vs Fc/Fc+) and was progressively increased 
going from γ-tocol (~ +0.5 V vs Fc/Fc+) to δ-tocol (~ +0.6 V vs Fc/Fc+). Although, the curves do 
not appear exactly similar presumably because of different scan rates and switching potentials, 
there is little or no difference between the tocopherols and tocotrienols having the same 
methylation pattern as seen by the location of the anodic peak in Figure 27-29. Therefore, we 
conclude that the electrochemical behavior of the tocopherols and tocotrienols is not a factor in 
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the biological differences observed between the two groups. On the other hand, the fact that the 
phenoxonium ion is accessible at physiological oxidation potentials (up to ~2.2 V vs standard 
hydrogen electrode (S.H.E) by hydroxyl radicals)35 with the presence of water in vivo suggests 
that the biological activity of the quinones should not be ignored.  
 
 
 
 
 
 
 
 
 
 
Figure 27: Bioanalytical Systems Inc. (BASI) Epsilon cyclic voltammetry at 100 mV/s of α-
tocopherol in dry CH2Cl2 with 77 mM tetrabutylammonium hexafluorophosphate vs. Ag wire 
and 300 mV/s of α-tocotrienol (2.4 mM) in dry CH2Cl2 with 77 mM tetrabutylammonium 
hexafluorophosphate vs. Ag wire. The scan of α-tocopherol was performed by Mikel Ghelfi 
using an unknown concentration.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28: BASI Epsilon cyclic voltammetry at 500 mV/s of γ-tocopherol (2.4 mM) in dry 
CH2Cl2 with 77 mM tetrabutylammonium hexafluorophosphate vs. Ag wire and 300 mV/s of γ-
tocotrienol (2.4 mM) in dry CH2Cl2 with 77 mM tetrabutylammonium hexafluorophosphate vs. 
Ag wire. 
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Figure 29: BASI Epsilon cyclic voltammetry at 300 mV/s of δ-tocopherol (2.4 mM) in dry 
CH2Cl2 with 77 mM tetrabutylammonium hexafluorophosphate vs. Ag wire and 500 mV/s of δ-
tocotrienol (2.4 mM) in dry CH2Cl2 with 77 mM tetrabutylammonium hexafluorophosphate vs. 
Ag wire. 
 
 
 
 
 
 
 
 
 
Figure 30: BASI Epsilon cyclic voltammetry at 100 mV/s of α-tocopherol (2.4 mM) in dry 
CH2Cl2 with 77 mM tetrabutylammonium hexafluorophosphate vs. Ag wire, 500 mV/s of γ-
tocopherol (2.4 mM) in dry CH2Cl2 with 77 mM tetrabutylammonium hexafluorophosphate vs. 
Ag wire, and 300 mV/s of δ-tocopherol (2.4 mM) in dry CH2Cl2 with 77 mM 
tetrabutylammonium hexafluorophosphate vs. Ag wire. 
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Figure 31: BASI Epsilon cyclic voltammetry at 300 mV/s of α-tocotrienol (2.4 mM) in dry 
CH2Cl2 with 77 mM tetrabutylammonium hexafluorophosphate vs. Ag wire, 300 mV/s of γ-
tocotrienol (2.4 mM) in dry CH2Cl2 with 77 mM tetrabutylammonium hexafluorophosphate vs. 
Ag wire, and 500 mV/s of δ-tocotrienol (2.4 mM) in dry CH2Cl2 with 77 mM 
tetrabutylammonium hexafluorophosphate vs. Ag wire. 
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Table 10: The extracted data from the experimental CV of the tocols. Ferrocene was used as an 
external standard.  
Compound Cathodic 
peaks 
(Epc) 
 
 
 
 
V 
Anodic 
peaks 
 (Epa) 
 
 
 
 
V 
Formal 
oxidation 
potential (E0) 
vs Ag wire  
Epc + Epa 
2 
 
V 
Formal 
reduction 
potential for 1st 
electron 
oxidation vs 
Fc/Fc+ 
 
V 
Reversibility Scan 
speed 
 
 
 
 
 
mV/s 
Ferrocene 0.431 0.711 0.571 - Reversible 100 
α-Ta  
 
0.557 
0.798 
1.130 0.844 + 0.27 Quasi 100 
α-T3 0.599 
0.807 
1.150  
2.171 
0.875 
1.489 
+ 0.30 
 
Quasi 300 
γ-T 0.925 1.16  
 
1.043 + 0.47 Quasi 500 
γ-T3 0.807 
0.940 
1.181 
2.150 
0.994 
1.545 
+ 0.42 
 
Quasi 300 
δ-T 1.041 
1.242 
1.260  
1.453 
1.151 
1.348 
+ 0.58 
 
Quasi 300 
δ-T3 1.232 
1.970 
1.010 
 
1.121 + 0.66 
 
Quasi 500 
a Data obtained from Mikel Ghelfi 
The fact that the quinones could be reduced by sodium borohydride and be oxidized back 
to the quinones in the presence of air as seen in the UV/vis experiments suggests that, in addition 
to being able to form cysteine adducts, the quinones are redox active in vitro and may exhibit 
similar activity in vivo. Therefore, differences in the redox activity of the quinones may also 
provide chemical evidence explaining the differences observed in biological samples. In this 
case, once the tocols are oxidized to the quinones, the quinones can be reduced by one-electron 
to the semiquinone radical or by two electrons to the neutral hydroquinone. It has been shown 
that the reduction of estrogen quinones to the estrogen hydroquinone is accomplished by 
NADPH-dependent cytochrome P450 reductase enzyme or NADPH: quinone oxidoreductase.95 
It is possible that similar enzymes can reduce the vitamin E quinones to the hydroquinones. Once 
the hydroquinone is formed, it can be oxidized back to the quinone by diatomic oxygen forming 
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two equivalents of superoxide anion (O2
•-) or one equivalent of hydrogen peroxide. The resulting 
superoxide anion or hydrogen peroxide are reactive oxygen species leading to a pro-oxidant 
activity generated by the redox cycling of quinones as seen in Scheme 4.95 The redox potential 
of the quinone is crucial for the ability of the hydroquinone to reduce diatomic oxygen.84 The 
more positive the redox potential of the quinone, the less likely the hydroquinone is to reduce 
molecular oxygen.84 Therefore, it is possible that differences in the redox potential of the vitamin 
E quinones can lead to differences in pro-oxidant activity and consequently, different 
cytotoxicities observed in cell culture assays supplemented with the tocols. Several studies have 
demonstrated the potential for pro-oxidant activity of vitamin E in cell culture assays and in 
humans.96–98 In a randomized control trial with 72 human patients 18-60 years old with a current 
diagnosis of asthma and taking regular corticosteroids, the supplementation of two capsules of 
vitamin E (250 mg vitamin E [d-α-tocopherol]) per day for six weeks was found to increase the 
levels of lipid peroxidation by 27% compared to the group receiving two identical placebo 
capsules.98  
 
Scheme 4: The proposed redox cycling of vitamin E quinones generating ROS superoxide (O2
•-) 
by the reduction of molecular oxygen. Figure adapted from Liehr and Roy (1990).95 
 
 The redox potential of the vitamin E quinones observed by CV are shown in Figures 32-
34. The reduction appears to go through two one-electron reduction processes. The first electron 
reduction is the reduction of the quinone to the semi-quinone radical anion which is then 
protonated. This reduction process appears to be quasi-reversible. The second electron reduction 
81 
 
is the reduction of the semi-quinone radical to the hydroquinone anion which is then protonated 
to form the neutral hydroquinone. This process appears to be less reversible. The lack of 
reversibility is likely a product of the homogeneous electron transfer and chemical proton 
transfers in solution.91 There does not appear to be significant difference in redox potential of the 
tocopheryl and tocotrienyl quinones having the same methylation pattern. However, the first 
electron redox potential decreases from δ- (~ -1.1 V vs Fc/Fc+) > γ- (~ -1.2 V vs Fc/Fc+) > α- (~ -
1.3 V vs Fc/Fc+) (Figures 35-36 & Table 11). This would suggest that the δ- and γ- tocol 
quinones are easier to reduce than α-tocol quinones, which may make them less susceptible to 
redox activity by the reduction of diatomic molecular oxygen. This pro-oxidant activity may be 
required under certain conditions in the cell. The apparent increased redox potential of α-
tocopheryl quinone compared to the other isoforms may also provide a reason for the preferential 
retention of α-tocopherol, though the differences are rather minor compared to the drastic 
differences in the rates of reactivity of the vitamin E quinones with thiols. The CV scan of α-
tocopheryl quinone only shows one reduction in the forward direction because it was not scanned 
to a far enough negative potential. The CV scan of α-tocotrienyl quinone was scanned at a rate 
much too quick (600 mV/s) and not far enough in the negative potential (only -1.0 V) for reliable 
results. Therefore, the redox potential of α-tocotrienyl quinone was omitted for the comparison 
towards the other isoforms. The limitations of this data include only one scan rate and only one 
concentration.  
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Figure 32: BASI Epsilon cyclic voltammetry at 300 mV/s of α-tocopheryl quinone (2.4 mM) in 
dry CH2Cl2 with 77 mM tetrabutylammonium hexafluorophosphate vs. Ag wire, and 600 mV/s 
of α-tocotrienyl quinone (2.4 mM) in dry CH2Cl2 with 77 mM tetrabutylammonium 
hexafluorophosphate vs. Ag wire. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 33: BASI Epsilon cyclic voltammetry at 300 mV/s of γ-tocopheryl quinone (2.4 mM) in 
dry CH2Cl2 with 77 mM tetrabutylammonium hexafluorophosphate vs. Ag wire, and 500 mV/s 
of γ-tocotrienol (2.4 mM) in dry CH2Cl2 with 77 mM tetrabutylammonium hexafluorophosphate 
vs. Ag wire. 
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Figure 34: BASI Epsilon cyclic voltammetry at 300 mV/s of δ-tocopheryl quinone (2.4 mM) in 
dry CH2Cl2 with 77 mM tetrabutylammonium hexafluorophosphate vs. Ag wire, and 300 mV/s 
of δ-tocotrienyl quinone (2.4 mM) in dry CH2Cl2 with 77 mM tetrabutylammonium 
hexafluorophosphate vs. Ag wire. 
 
 
Figure 35: BASI Epsilon cyclic voltammetry at 300 mV/s of α-tocopheryl quinone (2.4 mM) in 
dry CH2Cl2 with 77 mM tetrabutylammonium hexafluorophosphate vs. Ag wire, 300 mV/s of γ-
tocopheryl quinone (2.4 mM) in dry CH2Cl2 with 77 mM tetrabutylammonium 
hexafluorophosphate vs. Ag wire, and 300 mV/s of δ-tocopheryl quinone (2.4 mM) in dry 
CH2Cl2 with 77 mM tetrabutylammonium hexafluorophosphate vs. Ag wire. 
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Figure 36: BASI Epsilon cyclic voltammetry at 600 mV/s of α-tocotrienyl quinone (2.4 mM) in 
dry CH2Cl2 with 77 mM tetrabutylammonium hexafluorophosphate vs. Ag wire, 500 mV/s of γ-
tocotrienyl quinone (2.4 mM) in dry CH2Cl2 with 77 mM tetrabutylammonium 
hexafluorophosphate vs. Ag wire, and 300 mV/s of δ-tocotrienyl quinone (2.4 mM) in dry 
CH2Cl2 with 77 mM tetrabutylammonium hexafluorophosphate vs. Ag wire. 
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Table 11: The extracted data obtained from the cyclic voltammetry of the vitamin E quinones.  
 
Compound Cathodic 
peaks 
(Epc) 
 
 
 
 
V 
Anodic 
peaks 
 (Epa) 
 
 
 
 
V 
Formal 
reduction 
potential (E0) 
vs Ag wire  
Epc + Epa 
2 
 
V 
Formal 
reduction 
potential for 1st 
reduction vs 
Fc/Fc+ 
 
V 
Reversibility Scan 
speed 
 
 
 
 
 
mV/s 
Ferrocene 0.431 0.711 0.571 - Reversible 100 
α-TQa -0.875  -0.643  -0.759 -1.33 
 
Quasi 300 
α-T3Qb -0.547  -0.602 -0.575 -1.15 
 
Quasi 600 
γ-TQ -0.759  
-1.440  
-0.540  
-1.060  
-0.650  
-1.250 
-1.22 
 
Quasi 300 
γ-T3Q -0.837  
-1.540  
-0.609  
-1.112  
-0.723 
-1.326 
-1.29 
 
Quasi 500 
δ-TQ -0.712  
-1.480  
-0.487  
-1.071  
-0.600 
-1.276 
-1.17 
 
Quasi 300 
δ-T3Q -0.638  
-1.300  
-0.452  
-0.990  
-0.545 
-1.145 
-1.12 
 
Quasi 300 
aThe potential was not scanned far enough in the negative to catch the reduction of the second 
electron. bThe scan rate was too fast and not far enough for reliable results.  
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3. SUMMARY AND FUTURE PERSPECTIVES 
 
There is plenty of evidence in the literature describing how vitamin E is a fat-soluble 
antioxidant that inhibits lipid peroxidation. The antioxidant ability of the tocopherols and 
tocotrienols have been established in various solvents.34,45 The antioxidant ability decreases 
slightly in the order of α > γ ≈ β > δ-tocopherol (see Table 2) while there is no significant 
differences between the tocopherols and tocotrienols with the same methylation pattern.34,45  
That said, the differences in antioxidant ability are rather minor compared to the significant 
biological differences observed between the isoforms of vitamin E demonstrated in a fetal 
resorption assay in rats.34 The differences observed in the rat fetal resorption assay can be 
attributed to the preferential tissue and plasma retention of α-tocopherol by α-TTP and increased 
metabolism of the other isoforms by CYP4F2.34 Nonetheless, the evolutionary advantage for the 
retention of α-tocopherol is not known. Various studies using cultured cells incubated with the 
vitamin E isoforms have demonstrated the increased cytotoxicity of the non-α-tocols. The 
general trend observed is that δ-tocopherol is more cytotoxic than γ-tocopherol whereas 
cytotoxicity is generally not observed in the same cells supplemented with α-tocopherol. This 
may explain the preferential retention of α-tocopherol in animal tissues, that is, the α-
tocopheroxyl quinone is far less toxic than the other tocol quinones. In some cases, the 
tocotrienols have been shown to exhibit different biological effects from their tocopherol 
counterpart. To date, there has been no clear mechanism describing the different effects observed 
in cell culture supplemented with tocols. It is possible that the tocols are oxidized to the 
corresponding quinones depending on the oxidative status of the cell culture conditions, and the 
different effects observed are manifested by different reactivities between the tocol quinones. 
Cornwell’s group has demonstrated the ability for the non-α-tocopherol quinones to form thiol 
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adducts by a Michael-addition reaction.64,66 The quinone may form adducts with protein thiols 
which can induce different cell signalling cascades. The rate of reactivity of the quinones with 
thiols may correlate to the different activities observed in cell cultures. We have demonstrated 
that the rate of the reactivity with thiols is significantly greater with the δ-tocol quinones 
compared to the γ-tocol quinones whereas no reactivity is observed with the α-tocol quinones. 
These findings on the rate of reactivity are observed to follow roughly the degree of cytotoxicity 
observed in cell culture assays supplemented with the tocopherols and tocotrienols. On the other 
hand, there is no significant differences observed between the rate of reactivity of the tocopheryl 
and tocotrienyl quinones having the same methylation pattern. Therefore, the rates of reactivity 
of the quinones can not explain some of the different effects observed in vivo between the 
tocopherols and tocotrienols.34,51,52,58    
Our attention was then shifted towards the possibility of identifying differences in the 
ease of formation of the quinone using cyclic voltammetry. It was determined that the 
electrochemical behavior of the tocols are similar, however, a slight increase in redox potential 
(rightward shift, more positive) is observed when decreasing the extent of methylation on the 
chromanol ring. There does not seem to be significantly different behavior observed between the 
similarly methylated tocopherols and tocotrienols. This would suggest that rate of formation of 
the quinones is similar between the similarly methylated tocopherols and tocotrienols. Therefore, 
the electrochemical behavior of the tocols can not explain the differences observed in cell 
cultures supplemented with the tocotrienols.  We also used cyclic voltammetry to identify 
differences in the redox activity of the quinones. The reduction potential of the quinones with 
respect to methylation pattern on the quinone ring showed that as methylation increases the 
reduction potential increases, reflecting the greater difficulty of adding an electron to quinones 
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bearing more electron donating methyl groups (i.e., α-tocopheryl quinone has a more negative 
reduction potential than γ-tocopheryl quinone). There does not seem to be significantly different 
behavior exhibited between the tocopheryl quinones and tocotrienyl quinones with the same 
methylation pattern. Therefore, we may conclude that the different cytotoxic activities observed 
between the tocols having different methylation patterns correlates with the rate of reactivity of 
their quinones with thiols.  The difference in the biological activity of the tocopherols and 
tocotrienols is most likely a function of the way they sit in the membrane, inter-membrane 
transfer rates or possibly interfering with cholesterol biosynthesis by inhibiting HMG-CoA 
reductase.  
 From our results, we would emphasize the necessity of quantifying the presence of tocol 
quinone concentration of any cell culture assay supplemented with the tocols. Future studies 
should be aimed towards identifying which protein thiols the non-α-tocol quinones may form an 
adduct with. These proteins may be involved in redox sensitive cell signalling cascades like 
apoptosis or cellular antioxidant enzyme production. The cell signalling cascades leading to 
apoptosis are poorly understood and identifying these reactive protein thiols with vitamin E 
quinones may improve our understanding of apoptosis and redox sensitive cell signalling 
cascades. This may be achieved using a similar methodology developed by the Weerapana group 
for identifying reactive cysteines in the mitochondria proteome which utilizes reactive probes 
and mass spectrometry.71 In our case, the reactive probes would be an isotopically labelled non-
α-tocol quinone.  
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4. EXPERIMENTAL  
 
 
4.1 General Methods 
 
4.1.1 Materials and Reagents 
All reagents were purchased from Sigma-Aldrich Co., in Oakville, Ontario. All glassware was 
dried in an oven at 90°C overnight. The vitamin E rich vegetable oil suspension was graciously 
donated by Archer Daniels Midland Co. (ADM) and the TOCOMIN® palm kernel oil suspension 
was graciously donated by Carotech Sdn Bhd.  
 
4.1.2 Chromatography 
Column chromatography was performed on either silica gel (SiliCycle® SiliaFlash P60, particle 
size: 40-63μm, pore size: 60 Å) or neutral alumina gel (Sigma-Aldrich, pore size: 150 Å) with 
the solvent system stated. Thin layer chromatography (TLC) was performed on silica gel plates 
(Merck, TLC Silica gel 60 F254) or alumina plates (EM Science, Aluminiumoxid 60 F254 neutral). 
 
4.1.2 Spectroscopy 
Spectroscopic analysis of compounds was performed using 1H and 13C NMR acquired using a 
Bruker Avance DPX-400 Digital FT-NMR spectrometer at 400 MHz and 100 MHz respectively. 
The solvent used for analysis was deuterated chloroform (Cambridge Isotope Laboratories, Inc. 
deuterated chloroform, 99.8% pure). This solvent has a residual solvent peak corresponding to 
(1H=7.26 ppm, 13C=77.0 ppm). Chemical shifts are reported in ppm (δ) relative to tetramethyl 
silane (δ 0.00 ppm), multiplicity, number of protons and assignment. Multiplicity is described 
using the following abbreviations: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet). 
Low resolution mass spectra (MS) were recorded with a Carlo Erba/ Kratos GC/MS Concept 1S 
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double focusing mass spectrometer using electron impact (EI) or electrospray ionization (ESI) 
ionization methods. The molecular ions and major fragments are reported as m/z values. 
Absorption spectroscopy was performed using a Genesis 10X UV/Vis spectrophotometer with 
ScanLite software. Quartz cuvettes (3 mL, 1 cm path length) were used when recording 
absorbance values.  
 
4.2 Preparation of Starting Materials 
 
4.2.1 Synthesis of α-Tocopherol 
α-Tocopherol acetate (5.49 g, 11.6 mmol) was dissolved in ethanol (100 mL). KOH 
pellets (2.44 g, 43.5 mmol) were added to the solution and left to stir for 30 minutes at 10 °C.  
The reaction mixture was golden yellow. The solvent was partially evaporated in vacuo and 6 M 
HCl was added until the solution turned pink. The solution was extracted with diethyl ether. The 
organic layer was retained and dried with magnesium sulfate. The solvent was removed in vacuo 
and subjected to silica column chromatography with a hexane and dichloromethane (DCM) 
solvent gradient system starting with 20% DCM and finishing with 50% DCM. The solvent was 
removed from eluted materials to afford α-tocopherol (4.33 g, 10.1 mmol, 87.1%).  
 
Pale yellow oil, Rf = (0.35, hexanes/DCM 1:1, visualized by iodine and Hanessian’s stain).  
1H NMR (400 MHz, CDCl3) δ 4.20 (s, 1H, OH), 2.63 (t, 2H, CH2, J = 6.8 Hz), 2.19 (s, 3H, CH3), 
2.14 (s, 6H, 2 CH3), 1.80 (m, 2H, CH2), 1.60 (m, 5H, CH2, 3 CH), 1.5 (s, 3H, CH3), 1.23 (m, 
16H, 8 CH2), 0.91 (m, 12H, 4 CH3). 
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13C NMR (100 MHz, CDCl3) δ 145.56,  144.53,  122.63,  120.99,  118.46,  117.37,  74.54,  
39.82,  39.39,  37.48,  37.46,  37.44,  37.30,  32.81,  32.72,  31.56,  27.99,  24.81,  24.46,  23.81,  
22.73,  22.64,  21.05,  20.77,  19.76,  19.67,  12.22,  11.78,  11.29. 
 
4.2.2 Isolation of γ-Tocopherol  
A purchased vitamin E oil suspension from Archer Daniels Midland (ADM) (5.93 g) was 
subjected to silica column chromatography with a hexane and ethyl acetate solvent gradient 
system, usually starting with 1% ethyl acetate and finishing with 25% ethyl acetate. The solvent 
was removed from eluted materials in vacuo to afford γ-tocopherol (2.60 g, 6.24 mmol, 43.8% 
(w/w)). 
 
 
 
Clear oil, Rf = (0.51, hexanes/ethyl acetate 6:1, visualized by iodine stain).  
1H NMR (400 MHz, CDCl3) δ 6.40 (s, 1H, Ar-H), 4.22 (s, 1H, OH), 2.69 (m, 2H, CH2), 2.16 (s, 
3H, CH3), 2.13 (s, 3H, CH3), 1.75 (m, 3H, CH3), 1.56 (m, 5H, CH2, 3 CH), 1.26 (m, 18H, 9 
CH2), 0.90 (m, 12H, 4 CH3). 
13C NMR (100 MHz, CDCl3) δ 146.20,  145.77,  125.81,  121.58,  118.33,  112.13,  75.48,  
40.05,  39.39,  37.48,  37.46,  37.43,  37.29,  32.81,  32.70,  31.40,  27.99,  24.81,  24.46,  24.10,  
22.73,  22.64,  22.33,  21.02,  19.76,  19.67,  11.91,  11.87.   
MS (+EI) m/z 416 (M+, 100.0%), 191 (10.5 %), 151 (53.6%). 
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4.2.3 Isolation of δ-Tocopherol       
A purchased vitamin E oil suspension from ADM (5.93 g) was subjected to multiple 
silica chromatography columns with a hexane and ethyl acetate solvent gradient system, usually 
starting with 1% ethyl acetate and finishing with 25% ethyl acetate. The solvent was removed 
from eluted materials in vacuo to afford δ-tocopherol (0.80 g, 1.99 mmol, 13.5% (w/w)). 
 
Clear oil, Rf = (0.53, hexanes/ethyl acetate 17:3, visualized by iodine stain). 
1H NMR (400 MHz, CDCl3) δ 6.50 (d, 1H, Ar-H, J = 3.2 Hz), 6.41 (d, 1H, Ar-H, J = 3.2 Hz), 
4.22 (s, 1H, OH), 2.71 (m, 2H, CH2), 2.14 (s, 3H, CH3), 1.75 (m, 3H, CH3), 1.55 (m, 5H, CH2, 3 
CH), 1.26 (m, 18H, 9 CH2), 0.88 (m, 12H, 4 CH3). 
13C NMR (100 MHz, CDCl3) δ 147.65,  146.09,  127.37,  121.32,  115.60,  112.56,  75.58,  
39.96,  39.96,  39.39,  37.48,  37.43,  37.29,  32.81,  32.70,  31.34,  27.99,  24.81,  24.46,  24.12,  
22.73,  22.64,  22.53,  20.99,  19.76,  19.66,  16.07. 
MS (+EI) m/z 402 (M+, 100.0%), 177 (38.6%), 137 (72.9%). 
 
4.2.4 Isolation of α-Tocotrienol  
A commercial palm oil suspension, TOCOMIN® (25.0 g) was subjected to multiple silica 
columns with a hexane and ethyl acetate solvent gradient system starting with 1 % ethyl acetate 
and ending with 10 % ethyl acetate. Samples containing α-tocotrienol from previous years were 
also added to the column. The solvent was removed from eluted materials in vacuo to afford α-
Tocotrienol (1.50 g, 3.53 mmol, 6% (w/w)). 
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Orangey-yellow oil, Rf = (0.45, hexanes/ethyl acetate 9:1, visualized by iodine stain). 
1H NMR (400 MHz, CDCl3) δ 5.15 (t, 3H, CH), 4.20 (s, 1H, OH), 2.63 (t, 2H, CH2, J = 6.8 Hz), 
2.18 (s, 3H, CH3), 2.14 (s, 3H, CH3), 2.13 (s, 3H, CH3), 2.07 (m, 6H, 3 CH2),  1.97 (m, 4H, 2 
CH2), 1.80 (m, 2H, CH2), 1.62 (m, 12H, 4 CH3), 1.55 (m, 2H, CH2), 1.26 (s, 3H, CH3). 
13C NMR (100 MHz, CDCl3) δ 145.50,  144.58,  135.06,  134.97,  131.27,  124.44,  124.41,  
124.21,  122.65,  121.01,  118.47,  117.31,  74.30,  39.72,  39.70,  39.54,  31.58,  26.77,  26.61,  
25.71,  23.73,  22.23,  20.75,  17.70,  16.01,  15.90,  12.22,  11.79,  11.28. 
MS (+EI) m/z 424 (M+, 96.3%), 205 (23.1%), 165 (100.0%), 149 (71.1%), 69 (79.4%). 
 
4.2.5 Isolation of γ-Tocotrienol 
A commercial palm oil suspension, TOCOMIN® (25.0 g) was subjected to multiple silica 
columns with a hexane and ethyl acetate solvent gradient system starting with 1 % ethyl acetate 
and ending with 10 % ethyl acetate. The solvent was removed from eluted materials in vacuo to 
afford γ-Tocotrienol (2.90 g, 7.06 mmol, 11.6% (w/w)). 
 
Orangey-yellow oil, Rf = (0.41, hexanes/ethyl acetate 6:1, visualized by iodine stain).  
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1H NMR (400 MHz, CDCl3) δ 6.40 (s, 1H, Ar-H), 5.13 (m, 3H, 3 CH), 4.27 (s, 1H, OH), 2.71 (t, 
2H, CH2, J = 6.8 Hz), 2.16 (s, 3H, CH3), 2.15 (s, 3H, CH3), 2.10 (m, 6H, 3 CH2), 2.00 (m, 4H, 2 
CH2), 1.65 (m, 12H, 4 CH3), 1.29 (s, 3H, CH3).  
13C NMR (100 MHz, CDCl3) δ 146.26,  145.71,  135.11,  134.98,  131.27,  125.83,  124.42,  
124.35,  124.21,  121.63,  118.25,  112.15,  75.24,  39.79,  39.73,  39.70,  31.42,  26.77,  26.61,  
25.71,  24.01,  22.30,  22.22,  17.70, 16.01,  15.90,  11.92,  11.87.  
MS (+EI) m/z 410 (M+, 89.4%), 151 (100.0%), 69 (60.0%). 
 
4.2.6 Isolation of δ-Tocotrienol 
A commercial palm oil suspension, TOCOMIN® (25.0 g) was subjected to multiple silica 
columns with a hexane and ethyl acetate solvent gradient system starting. The solvent was 
removed from eluted materials in vacuo to afford δ-Tocotrienol (1.96 g, 4.94 mmol, 7.8% 
(w/w)). 
 
 
Golden yellow oil, Rf = (0.33, hexanes/ethyl acetate 17:3, visualized by iodine stain).  
1H NMR (400 MHz, CDCl3) δ 6.50 (d, 1H, Ar-H, J = 3.2 Hz), 6.40 (d, 1H, Ar-H, J = 3.2 Hz), 
5.13 (m, 3H, 3 CH), 4.28 (s, 1H, OH), 2.71 (t, 2H, CH2, J = 6.8 Hz), 2.15 (s, 3H, CH3), 2.12 (m, 
2H, CH2), 2.00 (m, 8H, 4 CH2), 1.77 (m, 2H, CH2), 1.65 (m, 14H, 4 CH3, CH2), 1.28 (s, 3H, 
CH3).  
13C NMR (100 MHz, CDCl3) δ 147.72,  146.01,  135.15,  134.98,  131.27,  127.83,  124.41,  
124.29,  124.19,  121.24,  115.62,  112.57,  75.33,  39.73,  39.71,  39.69,  31.36,  26.76,  26.60,  
25.71,  24.04,  22.49,  22.17,  17.69,  16.06,  16.01,  15.88.  
MS (+ESI) m/z 419 (M+ 23 (Na), 100.0%). 
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4.3 General Procedure for Synthesis of Quinones 
 
A 100-mL round bottom flask was charged with 6 g of flash chromatographic grade silica gel, a 
magnetic stirring bar and fitted with a rubber septum. Ceric ammonium nitrate (CAN, 
(NH₄)₂Ce(NO₃)₆) (1.65 g, 3.0 mmol, 2.1 eq.) was dissolved in 2.0 mL of water. This solution was 
added drop wise by syringe to the silica under continuous stirring which remained dry. The silica 
was left to stir for 5 minutes which produced a free-flowing yellow sand-like solid. 25 mL of 
DCM was added to the silica.  For the oxidation, 0.50 g of pure previously isolated tocols (~1.2 
mmol) was dissolved in 2 mL of DCM and added to the round bottom flask. The yellow solution 
turned dark orange immediately after the addition. The reaction was left to stir and monitored by 
TLC which determined the reaction to be complete after 30 minutes. The solid waste was filtered 
and washed with DCM. The solvent was removed in vacuo and the oil was subjected to silica 
column chromatography with a hexane and 10% ethyl acetate mixture. The solvent was removed 
from eluted materials to afford isolated products. 
 
4.3.1 Synthesis of α-Tocopheryl Quinone  
Pure α-tocopherol, 0.5020 g (1.16 mmol), and 1.3360 g (2.43 mmol) of CAN were used 
as starting materials. The reaction was monitored by TLC and showed one spot after 30 minutes 
with no starting material observable. The product was isolated by column chromatography to 
afford α-tocopheryl quinone (0.4245 g, 0.95 mmol, 81.9%).  
 
Bright yellow oil, Rf = (0.24, hexane/ethyl acetate 4:1, visualized by UV and iodine stain).  
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1H NMR (400 MHz, CDCl3) δ  2.58 (s, 2H, CH2),  2.06 (s, 3H, CH3),  2.03 (s, 6H, 2 CH3),  1.62 
(m, 23H, 10 CH2, 3 CH ), 1.25 (s, 3H, CH3), 0.91 (m, 12H, 4 CH3). 
13C NMR (100 MHz, CDCl3) δ 187.70,  187.24,  144.45,  140.54,  140.48,  140.18,  72.68,  
42.30,  40.27,  39.38,   37.61,  37.44,  37.29,  32.81,  32.78,  31.60,  27.98,  26.59,  24.81,  24.50,  
22.73,  22.63,  21.42,  21.32,  19.76,  19.71,  14.13,  12.38,  12.11. 
MS (+EI) m/z 446 (M+, 74.0%), 428 (100.0%), 378 (42.5%). 
 
4.3.2 Synthesis of γ-Tocopheryl Quinone  
Pure γ-tocopherol, 0.8983 g (2.15 mmol), and 2.4872 g (4.53 mmol) of CAN were used 
as starting materials. The reaction was monitored by TLC which showed two spots after 30 
minutes, neither of which was starting material. The products were isolated by column 
chromatography to afford para-γ-tocopheryl quinone (0.4106 g, 0.95 mmol, 44.2%) and ortho-γ-
tocopheryl quinone (0.2502 g, 0.58 mmol, 27.0%).  
Para-γ-tocopheryl quinone:  
 
 
 
Bright yellow oil, Rf = (0.18, hexane/ethyl acetate 6:1, visualized by UV and iodine stain).  
1H NMR (400 MHz, CDCl3) δ  6.55 (s, 1H, Ar-H),  2.50 (m, 2H, CH2), 2.05 (s, 3H, CH3), 2.03 
(s, 3H, CH3), 1.32 (m, 23H, 10 CH2, 3 CH), 1.24 (s, 3H, CH3), 0.91 (m, 12H, 4 CH3).
  
13C NMR (100 MHz, CDCl3) δ 187.64,  187.57,  149.38,  141.08,  140.67,  132.14,  72.53,  
42.42,  39.91,  39.37,  37.57,  37.44,  37.29,  32.81,  32.77,  27.98,  26.74,  24.80,  24.50, 23.97,  
22.73,  22.63,  21.39,  19.75,  19.69,  12.40,  12.06.  
MS (+EI) m/z 432 (M+, 84.0%), 414 (100.0%), 399 (15.0%). 
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Ortho-γ-tocopheryl quinone:  
 
Bright red oil, Rf = (0.23 hexane/ethyl acetate 6:1, visualized by UV and iodine stain). 
1H NMR (400 MHz, CDCl3) δ  2.45 (m, 2H, CH2), 2.05 (s, 3H, CH3), 1.97 (s, 3H, CH3), 1.74 (m, 
2 H, CH2), 1.59 (m, 21 H, 9 CH2, 3 CH),  1.34 (s, 3H, CH3), 0.88 (m, 12H, 4 CH3).
  
13C NMR (100 MHz, CDCl3) δ 180.85,  177.87,  163.31,  143.67,  134.18,  110.28,  81.38,  
39.94,  39.37,  37.44,  37.37,  37.28,  37.24,  32.80,  32.62,  31.60,  29.71,  27.99,  24.80,  24.44,  
23.89,  22.72,  22.63,  20.90,  19.75,  19.62,  15.37,  14.12,  13.73,  11.57.  
MS (+ESI) m/z 431 (M+, 100.0%), 360 (17.0%). 
 
4.3.3 Synthesis of δ-Tocopheryl Quinone 
Pure δ-tocopherol, 0.1021 g (0.25 mmol), and 0.2865 g (0.52 mmol) of CAN were used 
as starting materials. The reaction was monitored by TLC which showed two spots after 30 
minutes, neither of which was starting material. The products were isolated by column 
chromatography to afford p-δ-tocopheryl quinone (0.0311 g, 0.07 mmol, 29.7%) and o-δ-
tocopheryl quinone (δ-tocored) (0.0232 g, 0.06 mmol, 22.2%).  
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Para-δ-tocopheryl quinone:  
 
Bright yellow oil, Rf = (0.33, hexane/ethyl acetate 4:1, visualized by UV and iodine stain).  
1H NMR (400 MHz, CDCl3) δ  6.57 (m, 1H, Ar-H), 6.55 (m, 1H, Ar-H), 2.53 (m, 2H, CH2), 2.08 
(s, 3H, CH3), 1.62 (m, 2H, CH2), 1.28 (m, 24H, CH3, 9 CH2, 3 CH), 0.89 (m, 12H, 4 CH3).
  
13C NMR (100 MHz, CDCl3) δ 187.92,  187.79,  149.89,  145.99,  133.17,  132.38,  72.51,  
42.44,  39.89,  39.38,  37.56,  37.44,  37.29,  32.81,  32.78,  29.71,  27.98,  26.76,  24.80,  24.50,  
24.09,  22.73,  22.63,  21.40,  19.75,  19.69,  16.05.  
MS (+ESI) m/z 441 (M+ 23 (Na), 100.0%), 401 (90.0%). 
Ortho-δ-tocopheryl quinone:  
 
Bright red oil, Rf = (0.42, hexane/ethyl acetate 4:1, visualized by UV and iodine stain).  
1H NMR (400 MHz, CDCl3) δ  6.17 (s, 1H, Ar-H), 2.46 (m, 2H, CH2), 2.10 (s, 3H, CH3), 1.76 
(m, 2H, CH2), 1.62 (m, 5H, CH2, 3 CH), 1.34 (s, 3H, CH3), 1.28 (m, 16H, 8 CH2), 0.89 (m, 12H, 
4 CH3).
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13C NMR (100 MHz, CDCl3) δ 180.77,  177.94,  162.12,  150.27,  126.63,  112.20,  81.40,  
39.88,  39.37,  37.43,  37.37,  37.28,  37.23,  32.80,  32.63,  29.62,  27.99,  24.80,  24.44,  23.85,  
22.72,  22.63,  20.88,  19.75,  19.61,  17.87,  15.57.  
MS (+ESI) m/z 432 (M+1, 84.0%), 414 (100.0%). 
 
4.3.4 Synthesis of α-Tocotrienyl Quinone  
Pure α-tocotrienol, 0.2064 g (0.49 mmol), and 0.5647 g (1.03 mmol) of CAN were used 
as starting materials. The reaction was monitored by TLC which showed one spot after 30 
minutes with no starting material observable. The products were isolated by column 
chromatography to afford α-tocotrienyl quinone (0.1703 g, 0.39 mmol, 79.6%). 
 
Bright yellow oil, Rf = (0.22, hexane/ethyl acetate 6:1, visualized by UV and iodine stain). 
1H NMR (400 MHz, CDCl3) δ 5.12 (m, 3H, 3 CH), 2.57 (m, 2H, CH2), 2.01 (m, 19H, 3 CH3, 5 
CH2), 1.59 (m, 16H, 4 CH3, 2 CH2), 1.27 (s, 3H, CH3). 
13C NMR (100 MHz, CDCl3) δ 187.70,  187.23,  144.41,  140.54,  140.44,  140.19,  135.60,  
135.07,  131.27,  124.39,  124.14,  124.11,  72.68,  41.61,  40.30,  39.72,  26.77,  26.59,  26.51,  
25.71,  22.67,  21.35,  17.70,  16.03,  12.38,  12.30,  11.98. 
MS (+EI) m/z 440 (M+, 3.9%), 422 (3.9%), 69 (100.0%). 
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4.3.5 Synthesis of γ-Tocotrienyl Quinone  
Pure γ-tocotrienol, 0.4206 g (1.02 mmol), and 1.1743 g (2.14 mmol) of CAN were used 
as starting materials. The reaction was monitored by TLC which showed two spots after 30 
minutes, neither of which was starting material. The products were isolated by column 
chromatography to afford para-γ-tocotrienyl quinone (0.1841 g, 0.43 mmol, 42.3%) and ortho-γ-
tocotrienyl quinone, analogous to tocored (0.1536 g, 0.36 mmol, 35.3%).  
Para-γ-tocotrienyl quinone:  
 
Bright yellow oil, Rf = (0.17, hexanes/ethyl acetate 6:1, visualized by iodine stain). 
1H NMR (400 MHz, CDCl3) δ 6.55 (s, 1H, Ar-H), 5.14 (m, 3H, 3 CH), 2.52 (m, 2H, CH2), 2.08 
(m, 16H, 5 CH2, 2 CH3), 1.64 (m, 10H, 2 CH3, 2 CH2), 1.26 (s, 3H, CH3).  
13C NMR (100 MHz, CDCl3) δ 187.64,  187.55,  149.35,  141.08,  140.64,  135.72,  135.10,  
132.15,  131.28,  124.39,  124.09,  124.00,  72.55,  41.72,  40.00,  39.72,  26.77,  26.67,  26.58,  
25.71,  24.01,  23.44,  22.61,  17.70,  16.06,  12.40,  12.06. 
 MS (+EI) m/z 426 (M+, 2.07%), 295 (5.26%), 149 (21.81%), 69 (100.0%). 
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Ortho-γ-tocotrienyl quinone:  
 
Bright red oil, Rf = (0.22, hexanes/ethyl acetate 6:1, visualized by iodine stain).
  
1H NMR (400 MHz, CDCl3) δ 5.14 (m, 3H, 3 CH), 2.46 (m, 2H, CH2), 2.05 (m, 16H, 5 CH2,  
CH3), 1.70 (m, 16H, 4 CH3, 2 CH2), 1.36 (s, 3H, CH3).  
13C NMR (100 MHz, CDCl3) δ 180.76,  177.84,  163.19,  143.60,  136.15,  134.18, 124.33,  
124.23,  124.06,  124.00,  123.86,  123.19,  81.14,  40.04,  39.71,  32.18,  31.98,  29.70,  26.75,  
26.62,  26.51,  25.69,  23.79,  23.72,  23.39,  17.68,  16.00,  11.55. 
MS (+ESI) m/z 447 (M+23 (Na), 30.0%), 425 (M+1, 50.0%). 
 
4.3.6 Synthesis of δ-Tocotrienyl Quinone 
Pure δ-tocotrienol, 0.4206 g (1.02 mmol), and 0.5411 g (0.99 mmol) of CAN were used 
as starting materials. The reaction was monitored by TLC which showed two spots after 30 
minutes, neither of which was starting material. The products were isolated by column 
chromatography to afford para-δ-tocotrienyl quinone (0.0842 g, 0.20 mmol, 43.4%) and ortho-δ-
tocotrienyl quinone (0.0398 g, 0.10 mmol, 20.6%).  
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Para-δ-tocotrienyl quinone:  
 
Bright yellow oil, Rf = (0.30, hexanes/ethyl acetate 4:1, visualized by UV and iodine stain). 
1H NMR (400 MHz, CDCl3) δ 6.57 (m, 1H, Ar-H),  6.54 (m, 1H, Ar-H),  5.15 (m, 3H, 3CH), 
2.52 (m, 2H, CH2), 2.08 (m, 13H, 5 CH2, 1 CH3), 1.65 (m, 16H, 4 CH3, 2 CH2), 1.26 (s, 3H, 
CH3).  
13C NMR (100 MHz, CDCl3) δ 187.90,  187.78,  149.87,  145.99,  135.74,  135.10,  133.17,  
132.38,  131.27,  124.39,  124.07,  123.97,  72.51,  41.73,  39.97,  39.72,  39.70,  26.76,  26.67,  
26.57,  25.70,  24.13,  22.61,  17.69,  16.05,  16.03. 
MS (+ESI) m/z 435 (M+23 (+Na), 100.0%), 413 (M+1, (25.0%), 395 (70.0%). 
Ortho-δ-tocotrienyl quinone:  
 
Bright red oil, Rf = (0.40, hexanes/ethyl acetate 4:1, visualized by iodine stain). 
1H NMR (400 MHz, CDCl3) δ 6.18 (s, 1H, Ar-H), 5.11 (m, 3H, 3 CH), 2.48 (m, 2H, CH2), 2.10 
(m, 13H, 5 CH2, 1 CH3), 1.69 (m, 16H, 4 CH3, 2 CH2), 1.36 (s, 3H, CH3).  
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13C NMR (100 MHz, CDCl3) δ 180.72,  177.92,  162.05,  150.24,  136.07,  135.15,  131.31,  
126.64,  124.34,  123.98,  123.12,  112.20,  81.14,  39.72,  39.64,  29.62,  26.75,  26.51,  25.70,  
23.77,  22.04,  17.87,  17.69,  16.02,  15.97,  15.56. 
MS (+ESI) m/z 411 (M+1, 100.0%), 193 (15.0%). 
 
4.3.7 Synthesis of p-Benzoquinone 
 Purchased p-hydroxyquinone, 1.0026 g (9.11 mmol), and 10.4887 g (19.13 mmol) of 
CAN were used as starting materials. The reaction was monitored by TLC which showed one 
spot after 15 minutes with no starting material observable. The yellow product crystallized upon 
solvent removal in vacuo to afford p-benzoquinone (0.9382 g, 8.68 mmol, 95.3%). 
 
1H NMR (400 MHz, CDCl3) δ 6.81 (s, 4H, Ar-H). 
 
4.3.8 Synthesis of 1,3,5-Trimethyl Quinone 
Purchased 1,3,5-trimethyl hydroquinone, 1.0000 g (6.57 mmol), and 7.5643 g (13.80 
mmol) of CAN were used as starting materials. The reaction was monitored by TLC which 
showed one spot after 15 minutes with no starting material observable. The yellow product 
crystallized upon solvent removal in vacuo to afford 1,3,5-trimethyl quinone (0.8032 g, 5.35 
mmol, 81.4%).  
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1H NMR (400 MHz, CDCl3) δ 6.57 (q, 1H, Ar-H, J = 1.6 Hz), 2.05 (m, 9H, CH3). 
 
4.4 General Procedure for Synthesis of Quinone Thiol Conjugates 
 
The synthesized p-benzoquinone, 0.0500 g (0.46 mmol), was dissolved in 2 mL of ethanol in a 5-
mL vial. In a separate vial, 0.0802 g (0.51 mmol, 1.1 eq.) of N-acetyl cysteine was dissolved in 2 
mL of 0.1 mM Tris/HCl buffer at pH 8.5. The two vials were combined in a round bottom flask 
equipped with a magnetic stir bar and left to stir for 1 hour. The reaction was monitored by TLC 
in a solvent system of acetonitrile/methanol/acetic acid (9:1:0.1). To the reaction mixture, 10 mL 
of DCM was added followed by 3 mL of 6 M HCl and 10 mL of brine solution. The aqueous 
layer was washed with 3 portions of 5 mL of DCM. The combined organic layers were dried 
with Na2SO4. The product was isolated by column chromatography using the TLC solvent 
conditions. The solvent was removed in vacuo to afford an N-acetyl cysteine benzoquinone 
adduct (0.0912 g ,0.34 mmol, 73.9%). 
 
4.4.1 Synthesis of N-acetyl Cysteine p-Benzoquinone Conjugate 
p-benzoquinone, 0.0500 g (0.46 mmol), and  0.0802 g (0.51 mmol, 1.1 eq.) of N-acetyl 
cysteine were used as a starting material. TLC showed the presence of one spot after 1 hour. The 
product was isolated by column chromatography to afford N-acetyl cysteine p-benzoquinone 
conjugate (0.0912 g, 0.34 mmol, 73.9%). 
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Rf = (0.10, ACN/MeOH/HOAc 9:1:0.1, visualized by Hannessian’s stain)  
1H NMR (400 MHz, MeOD) δ 6.87 (d, 1H, Ar-H, J = 2.7 Hz), 6.70 (d, 1H, Ar-H, J = 8.7 Hz), 
6.68 (dd, 1H, Ar-H, J = 2.7 Hz J = 8.7 Hz), 4.40 (q, 1H, CH), 3.32 (m, 2H, CH2), 1.96 (s, 3H, 
CH3). 
MS (+EI) m/z 271 (M+, 12.0%), 142 (100.0%). 
 
4.4.2 Synthesis of N-acetyl Cysteine 2,3,5-Trimethylbenzoquinone Conjugate 
2,3,5-trimethylbenzoquinone, 0.1000 g (0.66 mmol), and 0.1196 g (0.73 mmol, 1.1 eq.) 
of N-acetyl cysteine were used as a starting material. TLC showed the presence of one spot after 
1 hour. The product was isolated by column chromatography to afford N-acetyl cysteine 2,3,5-
trimethylbenzoquinone conjugate (0.1512 g, 0.48 mmol, 72.7%). 
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Rf = (0.43, ACN/MeOH/HOAc 9:1:0.1, visualized by Hannessian’s stain)  
1H NMR (400 MHz, D2O) δ 4.18 (dd, 1H, CH, J = 4.0 Hz, J =8.8 Hz), 3.15 (dd, 1H, CH2, J = 4.0 
Hz J = 14.0 HZ), 2.89 (dd, 1H, CH2, J = 8.8 Hz J = 14.0 Hz), 2.28 (s, 3H, CH3), 2.06 (s, 3H, 
CH3), 2.04 (s, 3H, CH3), 1.79 (s, 3H, CH3). 
MS (-ESI) m/z 312 (M-1, 100.0%), 142 (100.0%). 
 
4.4.3 Synthesis of N-acetyl Cysteine γ-Tocopheryl Quinone Conjugate 
γ-tocopherol quinone, 0.0689 g (0.16 mmol), and 0.0294 g (0.18 mmol, 1.1 eq.) of N-
acetyl cysteine were used as a starting material. TLC showed the presence of one spot after 1 
hour. The product was isolated by column chromatography to afford N-acetyl cysteine of γ-
tocopheryl quinone conjugate (0.0713 g, 0.12 mmol, 75.0 %). 
 
Orange oil, Rf = (0.23, ACN/MeOH/HOAc 9:1:0.1, visualized by Hannessian’s stain)  
λmax = 265 nm, ε = ~ 3,300 M-1•cm-1, λmax = 307 nm, ε = ~ 2,700 M-1•cm-1  
1H NMR (400 MHz, MeOH) δ 4.18 (dd, 1H, CH, J = 4.0 Hz J =7.6 Hz), 3.65 (dd, 1H, CH2, J = 
4.0 Hz J = 14.0 HZ), 3.35 (dd, 1H, CH2, J = 8.8 Hz J = 14.0 Hz), 2.77 (m, 2H, CH2), 2.10 (s, 3H, 
CH3), 2.09 (s, 3H, CH3), 1.95 (s, 3H, CH3), 1.40 (m, 23H, 10 CH2, 3 CH), 1.23 (s, 3H, CH3), 
0.91 (m, 12H, 4 CH3). 
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13C NMR (100 MHz, CDCl3) δ 184.12,  182.97,  174.01,  171.44,  149.74,  142.24,  141.94,  
140.62,  72.17,  54.21,  41.21,  39.80,  39.15,  37.48,  37.14,  37.09,  37.01,  35.03,  32.60,  32.55,  
27.74,  25.46,  24.50,  24.16,  23.83,  21.70,  21.61,  21.28,  20.97,  18.90,  18.81,  11.49,  11.03. 
MS (+ESI) m/z 600 (M+5 (-H2O + Na), 46.0%), 578 (100.0%), 532 (80.0%). 
 
4.4.4 Synthesis of N-acetyl Cysteine δ-Tocopheryl Quinone Conjugate 
δ-tocopheryl quinone, 0.0447 g (0.11 mmol), and 0.0366 g (0.22 mmol, 2.1 eq.) of N-
acetyl cysteine were used as a starting material. TLC showed the presence of one spot after 1 
hour. The product was isolated by column chromatography to afford N-acetyl cysteine of δ-
tocopheryl quinone conjugate (0.0358 g, 0.06 mmol, 56.1 %). 
 
Orange oil, Rf = (0.18, ACN/MeOH/HOAc 9:1:0.1, visualized by Hannessian’s stain)  
λmax = 257 nm, ε = ~ 1,600 M-1•cm-1, λmax = 303 nm, ε = ~ 3,300 M-1•cm-1  
1H NMR (400 MHz, CDCl3) δ 6.92-7.05 (dd, 1H, NH), 6.66 (s, 1H, Ar-H)a, 6.62 (s, 1H, Ar-H)b 
4.64 (m, 1H, CH), 3.19 (m, 2H, CH2)
a, 2.95 (m, 2H, CH2)
b, 2.64 (m, 2H, CH2), 2.39 (s, 3H, 
CH3)
a,  2.19 (s, 3H, CH3)
b, 1.94 (s, 3H, CH3)
a, 1.89 (s, 3H, CH3)
b, 1.70 (m, 2H, CH2), 1.53 (m, 
3H, 3 CH), 1.23 (m, 24H, 9 CH2, 2 CH3
a,b), 0.87 (m, 12H, 4 CH3). 
13C NMR (100 MHz, CDCl3) δ 173.04,  171.86,  171.79,  150.87,  146.20,  145.99,  133.39,  
133.03,  129.92,  129.19,  115.73,  114.80,  114.69,  113.22,  74.32,  74.09,  53.08, 42.61,  42.46,  
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41.13,  39.38,  37.62,  37.53,  37.48,  37.30,  32.82,  32.78,  27.98,  26.31,  26.10,  24.81,  24.52,  
22.93,  22.74,  22.64,  21.57,  20.58,  19.75,  19.63,  16.68,  14.60. 
MS (+ESI) m/z 647 (10.0 %), 604 (M+23 (Na), 100.0%), 564 ((-H2O), 10.0%) 
Note: This reaction produced a mixture of regio-isomers that were not separated. The 1H NMR 
spectra showed two distinct signals for the regio-isomers designated as a and b. The ratio is 
approximately 1.2a : 1b. 
 
4.4.5 Synthesis of N-acetyl Cysteine γ-Tocotrienyl Quinone Conjugate 
γ-tocotrienyl quinone, 0.0189 g (0.04 mmol), and 0.0149 g (0.09 mmol, 2.2 eq.) of N-
acetyl cysteine were used as a starting material. TLC showed the presence of one spot after 1 
hour. The product was isolated by column chromatography to afford N-acetyl cysteine of γ-
tocotrienyl quinone conjugate (0.0081 g, 0.013 mmol, 34.7 %). 
 
Orange oil, Rf = (0.22, ACN/MeOH/HOAc 9:1:0.1, visualized by Hannessian’s stain)  
λmax = 265 nm, ε = ~ 3,300 M-1•cm-1, λmax = 307 nm, ε = ~ 2,700 M-1•cm-1  
1H NMR (400 MHz, CDCl3) δ 7.12 (d, 1H, NH, J = 6.8 Hz), 5.12 (m, 3H, 3 CH),  4.79 (m, 1H, 
CH), 3.14 (m, 2H, CH2), 2.82 (m, 2H, CH2), 2.20 (d, 3H, CH3), 2.10 (m, 16H, 2 CH3, 5 CH2), 
1.65 (m, 16H, 4 CH3, 2 CH2), 1.28 (s, 3H, CH3).    
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13C NMR (100 MHz, CDCl3) δ 177.09,  148.99,  136.07,  135.19,  131.30,  124.38,  124.11,  
124.03,  123.93,  123.85,  74.30,  39.72,  29.71,  26.76,  26.63,  26.58,  26.26,  26.15,  25.70,  
22.83,  22.68,  20.74,  17.69,  16.07,  16.02,  12.91,  12.83,  12.63,  12.49.  
MS (+ESI) m/z 659 (M+70, 25.0%), 628 (M+ 39 (K), 42.0 %), 626 ( 30.0%), 612 (M+23 (Na), 
100.0 %), 610 (70.0%), 381 (20.0%).  
 
4.4.6 Synthesis of N-acetyl Cysteine δ-Tocotrienyl Quinone Conjugate 
δ-tocotrienyl quinone, 0.0633 g (0.16 mmol), and 0.0522 g (0.32 mmol, 2.1 eq.) of N-
acetyl cysteine were used as a starting material. TLC showed the presence of one spot after 1 
hour. The product was isolated by column chromatography to afford N-acetyl cysteine of δ-
tocotrienyl quinone conjugate (0.0492 g, 0.08 mmol, 53.4 %). 
 
Orange oil, Rf = (0.17, ACN/MeOH/HOAc 9:1:0.1, visualized by Hannessian’s stain)  
λmax = 257 nm, ε = ~ 1,600 M-1•cm-1, λmax = 303 nm, ε = ~ 3,300 M-1•cm-1  
1H NMR (400 MHz, CDCl3) δ 6.71-6.79 (dd, 1H, NH), 6.68 (s, 1H, Ar-H)a, 6.64 (s, 1H, Ar-H)b, 
5.12 (m, 3H, 3 CH), 4.72 (m, 1H, CH), 3.13 (m, 2H, CH2)
a, 3.01 (m, 2H, CH2)
b, 2.65 (m, 2H, 
CH2), 2.41 (s, 3H, CH3)
a, 2.21 (s, 3H, CH3)
b, 1.89-2.12 (m, 13H, CH3, 5 CH2), 1.69 (m, 4H, 2 
CH2), 1.61 (m, 12H, 4 CH3), 1.28 (s, 3H, CH3)
a, 1.26 (s, 3H, CH3)
b.   
13C NMR (100 MHz, CDCl3) δ 176.57,  173.41,  171.66,  150.74,  150.70,  146.32,  146.11,  
136.00,  135.93,  135.16,  135.15,  133.11,  132.87,  131.30,  129.73,  129.19,  124.38,  124.05,  
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123.87,  123.82,  115.77,  114.67,  113.17,  74.39,  74.11,  53.73,  53.02,  41.66,  41.20,  41.08,  
39.72,  37.75,  26.77,  26.61,  26.34,  26.16,  25.71,  24.79,  22.97,  22.81,  22.67,  22.62,  20.71,  
17.70,  16.68,  16.08,  16.06,  16.03,  14.56. 
MS (+ESI) m/z 598 (M+23 (Na), 100.0%), 558 (5.0%), 437 (5.0%), 185 (10.0%). 
Note: This reaction produced a mixture of regio-isomers that were not separated. The 1H NMR 
spectra showed two distinct signals for the regio-isomers designated as a and b. The ratio is 
approximately 1.2a : 1b. 
 
4.5 Monitoring Reactivity of Quinones with Model Thiol  
 
Stock solutions of quinones (0.096 mg/mL) were prepared by dissolving 0.0096 g of quinone in 
100 mL of methanol and stored in a freezer at -20 ℃. One millilitre of the quinone stock solution 
was added to a 3-mL quartz cuvette and left to dry under nitrogen for about 1 hour. The cuvette 
containing dry quinone and a dry blank cuvette were placed in the respective cell holders of the 
spectrophotometer. The spectrophotometer was set up in a large two hand zipper lock Aldrich® 
Atmosbag with a nitrogen inlet and vacuum outlet to remove air and minimize the oxygen 
present. A solution of methanol was degassed by bubbling nitrogen through the solution while 
sonicating overnight.  Stock solutions of N-acetyl cysteine (0.145 mg/mL) were prepared by 
dissolving 0.0145g of N-acetyl cysteine in 100 mL of the desired buffer: 100 mM Tris/HCl pH 
8.5, 100mM Tris/HCl pH 7.5 or 100 mM bis-Tris/HCl pH 6.5. The stock solutions of N-acetyl 
cysteine were degassed by bubbling nitrogen through the solution while sonicating for 3 hours. 
The degassed methanol and the stock solutions of N-acetyl cysteine were placed inside the bag. 
The bag was purged with nitrogen five times to remove most of the oxygen. Two millilitres of 
methanol was added to the blank cuvette and the reaction cuvette. The cuvettes were shaken 
lightly by hand. One millilitre of the N-acetyl cysteine stock solution (4 eq.) was added to the 
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blank cuvette and the reaction cuvette. The increase in absorbance at 308 nm was recorded on 
Genesis 10x spectrophotometer every nine seconds using Vision Lite software. The reactions 
took between 5 minutes and 4 hours depending on conditions.  
 
4.5.1 Identification of Stoichiometry: Titration of Quinone with N-acetyl cysteine 
One millilitre of the γ-tocopherol quinone stock solution (0.096 mg/mL) was added to a 
3-mL quartz cuvette and left to dry under nitrogen for about 1 hour. The cuvette containing dry 
quinone and a dry blank cuvette were placed in the respective cell holders of the 
spectrophotometer. The spectrophotometer was set up in a large two hand zipper lock Aldrich® 
Atmosbag with a nitrogen inlet and vacuum outlet to minimize the oxygen present. The bag was 
purged with nitrogen five times to remove most of the oxygen. A stock solution of N-acetyl 
cysteine (0.361 mg/mL) was prepared fresh inside the bag by dissolving 0.0361 g in 100 mL of 
degassed 100 mM Tris/HCl buffer (pH 8.5). Two millilitres of the degassed methanol and 0.8 
mL of degassed 100 mM Tris/HCl buffer (pH 8.5) was added to both cuvettes. A 10 µL aliquot 
of the N-acetyl cysteine stock solution (0.1 eq.) was added to the cuvettes and the absorbance at 
308 nm was recorded every nine seconds for about 30 minutes until no increase in absorbance 
was observed. After this time, an additional 10 µL aliquot was added and the absorbance was 
measured every nine seconds. A total of 20 aliquots were added and the maximum absorbance 
after each addition was recorded.  
 
4.5.2 Identification of Suitable Solvent Systems 
One millilitre of the γ-tocopherol quinone stock solution was added to a 3-mL quartz 
cuvette and left to dry under nitrogen for about 1 hour. The cuvette containing dry quinone and a 
dry blank cuvette were placed in the respective cell holders of the spectrophotometer. The 
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spectrophotometer was set up in a large two hand zipper lock Aldrich® Atmosbag with a nitrogen 
inlet and vacuum outlet to minimize the oxygen present. A solution of methanol and isopropyl 
alcohol were degassed by bubbling nitrogen through the solution while sonicating overnight. A 
stock solution of N-acetyl cysteine (0.074 mg/mL) was prepared fresh inside the bag by 
dissolving 0.0074 g in 100 mL of degassed 100 mM Tris/HCl buffer (pH 8.5). The solvent 
systems studied were: 67% methanol (2mL), 58% methanol (1.75 mL), 50% methanol (1.5 mL), 
10% methanol (0.3 mL) and 67% isopropyl alcohol (2 mL). The appropriate amount of methanol 
or isopropyl alcohol was added to the sample cuvette and the blank cuvette. The sample cuvette 
was shaken lightly by hand to dissolve the quinone. One millilitre of the N-acetyl cysteine stock 
solution (2 eq.) was added to the blank cuvette and the reaction cuvette. The increase in 
absorbance at 308 nm was recorded on a Genesis 10x spectrophotometer every nine seconds 
using Vision Lite software. The reactions were monitored for about an hour.  
 
4.6 General procedure for Cyclic Voltammetry 
 
Cyclic voltammetry (CV) experiments were performed with a Bioanalytical Systems Inc. (BASI) 
Epsilon electrochemical workstation. All applicable compounds were dissolved with anhydrous 
DCM and deaerated by sparging N2 gas for 10 minutes. Solution concentrations were 
approximately 2.4 mM in analyte containing 77 mM supporting electrolyte tetrabutylammonium 
hexafluorophosphate (NBu4PF6). A typical three electrode setup was used including a platinum 
working electrode, Ag wire reference electrode and a platinum wire auxiliary electrode. Scan 
speeds are noted in the results.  
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